oxonic acid has been researched along with Liver Neoplasms in 387 studies
Oxonic Acid: Antagonist of urate oxidase.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib is the sole molecular-targeted agent showing a survival benefit in patients with advanced hepatocellular carcinoma (HCC)." | 9.19 | A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma. ( Arai, K; Chiba, T; Kanai, F; Kaneko, S; Ogasawara, S; Ooka, Y; Suzuki, E; Tawada, A; Yamashita, T; Yokosuka, O, 2014) |
| "Sorafenib is a multi-kinase inhibitor, which was approved as first-line treatment for patients with advanced hepatocellular carcinoma (HCC)." | 9.16 | Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma. ( Kang, WK; Lee, J; Lee, SJ; Lim, HY; Park, JO; Park, SH; Park, YS; Yim, DS, 2012) |
| "This is the first phase II study of S-1 monotherapy for patients with metastatic colorectal cancer after failure of both irinotecan- and oxaliplatin-containing regimens." | 9.12 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. ( Ahn, JB; Cho, BC; Chung, HC; Jeung, HC; Rha, SY; Roh, JK; Roh, WJ; Yoo, NC, 2006) |
| "The purpose of this study was to analyze the safety and feasibility of low-dose apatinib combined with S-1 as a second-line therapy or beyond in Chinese patients with pulmonary and/or hepatic metastases of nasopharyngeal carcinoma (NPC)." | 7.96 | Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma. ( Chen, J; Huang, X; Lin, J; Wu, G; Zhang, S; Zhou, L, 2020) |
| "No standard second-line chemotherapy has been yet established for gemcitabine-refractory biliary tract cancer (BTC)." | 7.88 | The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer. ( Furuse, J; Kasuga, A; Kawai, K; Kobayashi, T; Nagashima, F; Naruge, D; Okano, N; Yamauchi, Y, 2018) |
| "We report curative resection of an advanced intrahepatic cholangiocarcinoma that responded well to combined S-1 and gemcitabine chemotherapy(GS therapy)." | 7.83 | [Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy]. ( Fukuda, S; Kuga, Y; Moriya, T; Nishida, T, 2016) |
| "Sorafenib and conventional systemic cytotoxicity chemotherapy are currently being used in parallel for the patients with advanced hepatocellular carcinoma (HCC)." | 7.80 | Combination of oxaliplatin and S-1 versus sorafenib alone in patients with advanced hepatocellular carcinoma. ( Hu, X; Li, Q; Li, Y; Liang, R; Liao, S; Liao, X; Lin, Y; Liu, Z; Lv, Y; Yuan, C; Zhang, J, 2014) |
| "Sorafenib and S-1 (one mixed formulation containing 5-FU prodrug and dihydropyrimidine dehydrogenase inhibitor) were two effective agents against hepatocellular carcinoma (HCC), but whether they had synergistic effects remained unclear." | 7.79 | Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1. ( Cai, JP; Hao, XY; Hou, X; Lai, YR; Liang, LJ; Yin, XY; Zhai, JM; Zhang, LJ, 2013) |
| "The aim of this study was to determine the feasibility of S-1 plus oxaliplatin (SOX) or capecitabine plus oxaliplatin (XELOX) as first-line therapy for patients with initially unresectable metastases from colorectal cancer." | 7.79 | Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer. ( Akiba, T; Enomoto, H; Kawahara, H; Toyama, Y; Watanabe, K; Yanaga, K, 2013) |
| "We report a patient with type 3 gastric cancer with peritoneal dissemination and hydronephrosis who was successfully treated with intraperitoneal infusion of paclitaxel and oral administration of S-1." | 7.74 | Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer. ( Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Takatsuka, Y; Takiuchi, D; Tamura, S; Tomita, N, 2007) |
| "The patient was diagnosed with advanced gastric cancer (type-3) with lymphangitis carcinomatosa of the lung." | 5.32 | [A case of advanced gastric cancer with lymphangitis carcinomatosa of the lung, successfully treated with paclitaxel and TS-1]. ( Kawabata, H; Murata, A; Nakajima, H; Takase, I; Watanabe, T, 2003) |
| "Sorafenib is the sole molecular-targeted agent showing a survival benefit in patients with advanced hepatocellular carcinoma (HCC)." | 5.19 | A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma. ( Arai, K; Chiba, T; Kanai, F; Kaneko, S; Ogasawara, S; Ooka, Y; Suzuki, E; Tawada, A; Yamashita, T; Yokosuka, O, 2014) |
| "Sorafenib is a multi-kinase inhibitor, which was approved as first-line treatment for patients with advanced hepatocellular carcinoma (HCC)." | 5.16 | Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma. ( Kang, WK; Lee, J; Lee, SJ; Lim, HY; Park, JO; Park, SH; Park, YS; Yim, DS, 2012) |
| "This is the first phase II study of S-1 monotherapy for patients with metastatic colorectal cancer after failure of both irinotecan- and oxaliplatin-containing regimens." | 5.12 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. ( Ahn, JB; Cho, BC; Chung, HC; Jeung, HC; Rha, SY; Roh, JK; Roh, WJ; Yoo, NC, 2006) |
| "The purpose of this study was to analyze the safety and feasibility of low-dose apatinib combined with S-1 as a second-line therapy or beyond in Chinese patients with pulmonary and/or hepatic metastases of nasopharyngeal carcinoma (NPC)." | 3.96 | Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma. ( Chen, J; Huang, X; Lin, J; Wu, G; Zhang, S; Zhou, L, 2020) |
| "No standard second-line chemotherapy has been yet established for gemcitabine-refractory biliary tract cancer (BTC)." | 3.88 | The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer. ( Furuse, J; Kasuga, A; Kawai, K; Kobayashi, T; Nagashima, F; Naruge, D; Okano, N; Yamauchi, Y, 2018) |
| "S-1, an oral 5-fluorouracil (5-FU)-based medicine that combines tegafur, gimeracil and oteracil potassium is commonly used as an adjuvant chemotherapeutic drug for the treatment of colorectal cancer." | 3.83 | Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy. ( Kokuryo, T; Nagino, M; Uehara, K; Yamaguchi, J; Yamauchi, K; Yokoyama, Y, 2016) |
| "We report curative resection of an advanced intrahepatic cholangiocarcinoma that responded well to combined S-1 and gemcitabine chemotherapy(GS therapy)." | 3.83 | [Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy]. ( Fukuda, S; Kuga, Y; Moriya, T; Nishida, T, 2016) |
| "Sorafenib and conventional systemic cytotoxicity chemotherapy are currently being used in parallel for the patients with advanced hepatocellular carcinoma (HCC)." | 3.80 | Combination of oxaliplatin and S-1 versus sorafenib alone in patients with advanced hepatocellular carcinoma. ( Hu, X; Li, Q; Li, Y; Liang, R; Liao, S; Liao, X; Lin, Y; Liu, Z; Lv, Y; Yuan, C; Zhang, J, 2014) |
| "Sorafenib and S-1 (one mixed formulation containing 5-FU prodrug and dihydropyrimidine dehydrogenase inhibitor) were two effective agents against hepatocellular carcinoma (HCC), but whether they had synergistic effects remained unclear." | 3.79 | Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1. ( Cai, JP; Hao, XY; Hou, X; Lai, YR; Liang, LJ; Yin, XY; Zhai, JM; Zhang, LJ, 2013) |
| "The aim of this study was to determine the feasibility of S-1 plus oxaliplatin (SOX) or capecitabine plus oxaliplatin (XELOX) as first-line therapy for patients with initially unresectable metastases from colorectal cancer." | 3.79 | Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer. ( Akiba, T; Enomoto, H; Kawahara, H; Toyama, Y; Watanabe, K; Yanaga, K, 2013) |
| "The subjects consisted of 23 patients with pancreatic adenocarcinoma who had liver metastases and were treated with S-1 and gemcitabine as the first-line treatment." | 3.74 | Quantitative analysis of vascular endothelial growth factor in liver metastases from pancreatic carcinoma as a predictor of chemotherapeutic effect and prognosis. ( Ishihara, T; Kobayashi, A; Matsuyama, M; Tawada, K; Tsuyuguchi, T; Yamaguchi, T; Yokosuka, O, 2008) |
| "High-dose toremifene therapy (120 mg/day) is useful for the recurrence of receptor-positive breast cancer." | 3.74 | [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy]. ( Murakami, S; Yamamoto, Y, 2007) |
| "We report a patient with type 3 gastric cancer with peritoneal dissemination and hydronephrosis who was successfully treated with intraperitoneal infusion of paclitaxel and oral administration of S-1." | 3.74 | Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer. ( Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Takatsuka, Y; Takiuchi, D; Tamura, S; Tomita, N, 2007) |
| "We had 2 patients with marked shrinkage of liver metastasis by administration of the oral fluorinated pyrimidine anticancer drug S-1 for advanced/recurrent breast cancer that was resistant to taxane and another antitumor drugs." | 3.73 | [Two patients effectively treated with S-1 therapy for liver metastasis of breast cancer resistant to other anticancer drugs]. ( Sato, Y, 2006) |
| "Gemcitabine was administered at a dose of 1000 mg/m2 by 30 min infusion on days 1, S-1 40 mg/m2 orally twice daily and LV 25 mg orally twice daily on days 1 to 7 every 2 weeks." | 2.90 | A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer. ( Hakuta, R; Hamada, T; Ijichi, H; Isayama, H; Ishigaki, K; Kishikawa, T; Kogure, H; Koike, K; Matsubara, S; Mizuno, S; Nakai, Y; Saito, K; Saito, T; Sasaki, T; Tada, M; Takahara, N; Takeda, T; Tateishi, K; Uchino, R; Yamamoto, N, 2019) |
| "Recent gastric cancer clinical trials have aimed to establish the efficacy of combination therapy over monotherapy, however, the role for genomic biomarkers in these trials has remained largely unexplored." | 2.87 | Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301/TOP002 phase III clinical trial. ( Das, K; Imamura, H; Nishikawa, K; Sugimoto, N; Taguri, M; Tan, P; Tsuburaya, A; Yoshida, K, 2018) |
| " Thus, our study aimed to examine the efficacy and safety of Endostar continuous intravenous infusion combined with S-1 and oxaliplatin (SOX) chemotherapy in treating such patients." | 2.87 | Endostar continuous intravenous infusion combined with S-1 and oxaliplatin chemotherapy could be effective in treating liver metastasis from gastric cancer. ( Guo, X; Li, Y; Sui, Y; Tan, X; Wang, M; Yang, H, 2018) |
| "Unresectable advanced hepatocellular carcinoma is a heterogeneous disease, for which sorafenib is the first targeted agent approved for first-line therapy, and treatment options for patients with sorafenib-refractory advanced hepatocellular carcinoma are limited." | 2.84 | S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial. ( Date, Y; Fang, X; Furuse, J; Hidaka, H; Ikeda, M; Kaneko, S; Kawazoe, S; Kudo, M; Moriguchi, M; Numata, K; Ohkawa, S; Okusaka, T; Sato, Y; Takeuchi, M; Tanaka, H, 2017) |
| " Grade 3 or worse adverse events were less frequent in the elderly group receiving SOX than in the elderly group receiving CS except for the low incidence of sensory neuropathy (5." | 2.82 | Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer. ( Amagai, K; Bando, H; Chin, K; Fujii, H; Gotoh, M; Hamada, C; Hironaka, S; Hyodo, I; Imamura, H; Miwa, H; Nishikawa, K; Nishina, T; Niwa, Y; Shimada, K; Sugimoto, N; Tanabe, S; Tsuda, M; Tsuji, A; Yamada, Y; Yamaguchi, K; Yasui, H, 2016) |
| " We determined the recommended dosage for CDDP-TAI plus S-1 combination therapy for advanced HCC." | 2.79 | Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial. ( Hosoi, H; Ikeda, M; Kondo, S; Mitsunaga, S; Morizane, C; Okusaka, T; Shimizu, S; Terazawa, T; Ueno, H, 2014) |
| " The common adverse drug reactions were a decrease in hemoglobin levels, hypoalbuminemia, and anorexia, which were mild in severity (grades 1-2)." | 2.79 | Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma. ( Arioka, H; Asaoka, Y; Ikeda, M; Koike, K; Kojima, Y; Kondo, S; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Sakamoto, Y; Shiina, S; Shimizu, S; Tateishi, R; Ueno, H, 2014) |
| "S-1 in patients with advanced gastric cancer (AGC)." | 2.78 | Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer. ( Lu, XY; Wang, ML; Wang, X; Yang, JF; Yu, HG; Zhou, LY, 2013) |
| "Paclitaxel (160 mg/m²) was administered by infusion for 3 h on the first day." | 2.76 | A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer. ( Goto, H; Haruta, J; Ina, K; Iwase, H; Kumada, T; Shimada, M; Shinoda, M; Sugihara, M; Tsuzuki, T, 2011) |
| "Patients with advanced gastric cancer, naive to chemotherapy or not refractory to fluoropyrimidine, were enrolled." | 2.75 | Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer. ( Boku, N; Hironaka, S; Kojima, T; Machida, N; Muro, K; Shitara, K; Taku, K; Ueda, S; Yamazaki, K; Yokota, T, 2010) |
| "We report a patient with gallbladder cancer and multiple liver and lymph node metastases which completely responded to S-1, an oral fluoropyrimidine anticancer drug." | 2.73 | [Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report]. ( Furuse, J; Ishii, H; Nakachi, K; Shimizu, S; Suzuki, E; Yoshino, M, 2007) |
| "We treated 12 patients with advanced gastric cancer with 80 mg/m2 of S-1 for 21 days and 60 mg/m2 of cisplatin (CDDP) on day 8 every 5 weeks." | 2.71 | Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer. ( Baba, H; Endo, K; Ikeda, Y; Kohnoe, S; Okamura, T; Toh, Y; Yamamoto, M, 2003) |
| "However, recurrence occurred and the patient achieved complete response following tegafur/gimeracil/oteracil-based chemotherapy." | 2.55 | Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature. ( Ikeyama, M; Ishizone, S; Nakayama, J; Yoshizawa, J, 2017) |
| "G-CSF-producing gastric cancer is rare; thus, we take this opportunity to report our case and to summarize the G-CSF-producing gastric cancer cases reported in Japan." | 2.50 | [Case report of chemotherapeutic control of a gastric cancer producing granulocyte-colony stimulating factor]. ( Misawa, S; Miyamoto, M, 2014) |
| "We describe a patient who had gastric cancer with liver metastases." | 2.50 | Preoperative chemotherapy with a trastuzumab-containing regimen for a patient with gastric cancer and hepatic metastases. ( Bu, ZD; Ji, JF; Ji, X; Li, SX; Li, ZY; Shan, F; Wu, AW; Wu, XJ; Zhang, LH; Zong, XL, 2014) |
| "A 67-year-old man with bladder cancer who was treated with transurethral resection of bladder tumour(TUR-Bt)and chemotherapy at the age of 59 years was diagnosed as having urothelial cancer by biopsy 8 years later." | 2.49 | [A case of quadruple cancer of the liver, stomach, bladder, and ureter]. ( Fukuoka, M; Nishizawa, Y; Omura, N; Tachibana, S; Tatara, T; Tatsumi, Y; Yoshida, T; Yoshimura, H, 2013) |
| "The prognosis for hepatocellular carcinoma with extrahepatic metastasis or vascular invasion is very poor." | 2.47 | [A successful case of systemic chemotherapy followed by liver resection for advanced hepatocellular carcinoma with highly vascular invasion and multiple pulmonary metastases]. ( Kakisaka, T; Kamachi, H; Kamiyama, T; Matsushita, M; Mizukami, T; Nakanishi, K; Tahara, M; Taniguchi, M; Todo, S; Yokoo, H, 2011) |
| "We encountered a case of gastric cancer accompanied with liver metastasis, which had a good response to chemotherapy of S-1." | 2.47 | [A case of long-term survival after undergoing S-1 based multidisciplinary therapy for liver metastasis of gastric cancer]. ( Amano, R; Hirakawa, K; Ito, G; Kimura, K; Kubo, N; Maeda, K; Muguruma, K; Nagahara, H; Nakata, B; Noda, E; Ohira, M; Sakurai, K; Sawada, T; Tanaka, H; Yamada, N; Yashiro, M, 2011) |
| "Without any sign of infection, leukocytosis developed around the 30th POD." | 2.46 | Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor. ( Asada, Y; Fujisawa, K; Iida, Y; Kawaguchi, M; Mitsui, T; Miura, S; Munemoto, Y; Sudo, Y; Takehara, A; Terada, T, 2010) |
| "A-67-year old man was diagnosed with gastric cancer and a liver tumor." | 1.51 | [A Case of Gastric Endocrine Carcinoma with a Huge Liver Metastasis]. ( Kawaoka, T; Kubo, H; Miyahara, M; Nabeya, M; Nishida, Y; Saeki, S; Sasaki, S; Tamesa, T; Tokunou, K; Yamamoto, S; Yamashita, Y, 2019) |
| "We report a case of recurrent gastric cancer that was successfully treated by S-1 chemotherapy." | 1.51 | [A Case of Recurrent Gastric Cancer Successfully Treated by S-1 Chemotherapy]. ( Hata, M; Hoshino, H; Imamoto, H; Kawada, J; Kim, Y; Nagai, K; Nishino, M; Ogino, T; Okano, M; Okuyama, M; Tanizaki, K; Tsujinaka, T, 2019) |
| "In our case, we report a gallbladder cancer with portal vein thrombus." | 1.48 | Gallbladder cancer with tumor thrombus in the portal vein: A case report. ( Bai, XL; Chen, W; Liang, TB; Ma, T; Tu, JJ; Zhang, XZ, 2018) |
| "This study suggests that platelets in gastric cancer stroma may create a favorable microenvironment for chemoresistance." | 1.46 | Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study. ( Fushida, S; Kinoshita, J; Miyashita, T; Ninomiya, I; Ohta, T; Oyama, K; Saito, H; Tajima, H; Tsukada, T; Yamaguchi, T, 2017) |
| "A 77-year-old man was diagnosed with gastric cancer with synchronous single liver metastasis and portal vein thrombus." | 1.46 | [A Case of Long-Term Survival of a Patient with Gastric Cancer with Synchronous Liver Metastasis and Portal Vein Thrombus after Multidisciplinary Treatment]. ( Adachi, Y; Mizukami, Y; Nomura, H; Okamura, M; Ota, S; Sumii, A; Tsuboi, K, 2017) |
| "Although the prognosis of gastric cancer with synchronous liver metastases is very poor, it is possible for survival to be prolonged with multimodality therapy." | 1.46 | [A Case of Advanced Gastric Cancer with Synchronous Liver Metastases Responding to Preoperative Combination Chemotherapy with S-1 plus Oxaliplatin(SOX)]. ( Ebisui, C; Fukuchi, N; Hamano, R; Kinuta, M; Kitahara, T; Minoji, T; Murata, K; Ohishi, K; Okamura, S; Yanagisawa, T; Yokouchi, H, 2017) |
| "For patients with liver metastases from gastric cancer (LMGC), combination chemotherapy with fluoropyrimidines and platinum agents has been recognized as standard treatment." | 1.43 | Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin. ( Ohi, H; Ozaki, T; Seki, H; Yabusaki, H, 2016) |
| "The prognosis of Stage IV b pancreatic cancer is extremely poor; the mean survival time is 2-4 months." | 1.42 | [A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy]. ( Fujino, Y; Goto, H; Hasegawa, H; Kakinoki, K; Katsura, M; Ohara, T; Oshikiri, T; Oyama, M; Sendo, H; Sugimoto, T; Sugiyama, H; Tominaga, M; Ueda, Y; Yamashita, H; Yasuda, T, 2015) |
| "Recent advances in gastric cancer chemotherapy have made macroscopic complete resection possible in some patients with stage IV disease." | 1.42 | Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer. ( Fushida, S; Kinoshita, J; Makino, I; Miyashita, T; Nakamura, K; Ninomiya, I; Ohta, T; Okamoto, K; Oyama, K; Tajima, H; Takamura, H; Tsukada, T, 2015) |
| " The CT-guided percutaneous radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) procedure was performed on the liver metastasis using degradable starch microspheres (DSM)." | 1.42 | [Liver Metastasis in a Gastric Cancer Patient--A Case of Successful Radiofrequency Ablation Combined with Degradable Starch Microspheres Transcatheter Arterial Chemoembolization]. ( Dono, K; Hatano, H; Hirabuki, N; Hirota, M; Imamura, H; Nakata, S; Noda, T; Oh, RJ; Ohara, N; Ohira, R; Yakushiji, H; Yasumoto, T, 2015) |
| "We encountered a case of pancreatic cancer with multiple liver metastases that developed postoperatively and showed a complete response with S-1 monotherapy for a long time." | 1.42 | [A Case of Pancreatic Cancer with Multiple Liver Metastases That Developed Postoperatively and Showed a Complete Response with S-1 Monotherapy]. ( Asai, K; Baba, M; Hiratsuka, M; Katsuyama, S; Murata, M; Saso, K; Sawami, H; Takahashi, H; Takayama, O; Tanaka, N; Yagi, T; Yamada, M; Yamamoto, M, 2015) |
| "A 62-year-old man was diagnosed with gastric cancer and underwent distal gastrectomy, and D1+b lymph node dissection." | 1.42 | [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)]. ( Hosoda, Y; Kawada, J; Kim, Y; Nagai, K; Nishino, M; Okano, M; Okuyama, M; Tsujinaka, T; Yamasaki, M; Yasui, M, 2015) |
| "Therefore, a diagnosis of gastrointestinal stromal tumor (GIST) was made." | 1.42 | [A Case of Intraductal Growth Pattern Gastrointestinal Stromal Tumor of the Stomach That Was Difficult to Diagnose by Biopsy]. ( Hasegawa, J; Hirota, M; Ikenaga, M; Kameda, C; Kawabata, R; Koga, C; Miwa, H; Murakami, M; Noura, S; Ozato, Y; Shimizu, J; Yoshikawa, M, 2015) |
| "The patient was diagnosed with gastric cancer with liver metastasis, Stage Ⅳ, and treated with chemotherapy (S-1 plus CDDP)." | 1.42 | [A Case Report--A Synchronous Liver Metastasis from Gastric Cancer Treated with Chemotherapy, Surgical Resection of the Gastric Cancer, and RFA of the Liver Metastasis]. ( Ishigami, E; Kawamoto, J; Miyazaki, M; Nakada, S; Shinoda, K; Teranaka, R; Yoichi, T, 2015) |
| "He was diagnosed with advanced gastric cancer with multiple liver metastases." | 1.42 | [Multidisciplinary Therapy for Advanced Gastric Cancer with Liver and Brain Metastases]. ( Ako, E; Hirakawa, T; Kametani, N; Kanehara, I; Kato, Y; Komoto, M; Nakazawa, K; Nishimura, S; Taenaka, N; Tanaka, R; Yamada, N; Yamagata, S, 2015) |
| "Abdominal computed tomography showed gastric cancer invasion to the left liver lobe." | 1.42 | [A Case of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy]. ( Kawamoto, S; Maeno, H; Munechika, T; Nagao, S; Nomi, M; Okamoto, T; Sasaguri, T; Sueishi, K; Tanaka, K; Yonemitsu, K, 2015) |
| "The patient had no recurrence for 1 year after the last surgery." | 1.42 | [A Case of Repeat Liver Resection after Laparoscopic Resection of a Synchronous Liver Metastasis of Colon Cancer]. ( Arai, S; Kataoka, M; Miyazawa, K; Oeda, Y; Shiobara, M; Suda, K; Takagi, T; Wakatsuki, K; Yoshioka, S, 2015) |
| "The prognosis of pancreatic cancer is dismal compared to other types of cancer, and for a Stage Ⅳb cancers, the 5-year survival rate is reported to be approximately 3%." | 1.42 | [Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy]. ( Hiratsuka, M; Ishibashi, Y; Ito, Y; Morita, A; Omori, K; Saito, H; Suda, H; Suematsu, Y; Takahashi, M; Wakabayashi, K, 2015) |
| "A 58-year-old woman with advanced gastric cancer underwent total gastrectomy in May 2012." | 1.42 | Complete Response Obtained with S-1 Plus CDDP Therapy in a Patient with Multiple Liver Metastases from Gastric Cancer. ( Inagaki, M; Iwagaki, H; Nonoshita, T; Otsuka, S, 2015) |
| "Unresectable metastatic colorectal cancer with very slow tumour growth rate does not necessarily require for strong short-interval chemotherapy." | 1.40 | Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer. ( Akiba, T; Enomoto, H; Kawahara, H; Tomoda, M; Watanabe, K; Yanaga, K, 2014) |
| "He was diagnosed with sigmoid cancer with multiple liver and lung metastases." | 1.40 | [A case of Stage IV sigmoid colon cancer that achieved long-term survival with oral anticancer drugs]. ( Hasegawa, Y; Hatanaka, M; Iwata, H, 2014) |
| "She was diagnosed with advanced lower rectal cancer with multiple liver and pulmonary metastases." | 1.40 | [Induction chemotherapy with S-1/oxaliplatin prevented colostomy in a patient with advanced rectal cancer]. ( Goto, T; Sasaki, K; Shimao, K; Yano, M, 2014) |
| " The goal of this study was to evaluate the efficacy and safety of combination therapy of cetuximab and S-1 combined with oxaliplatin (SOX) in Chinese patients with advanced gastric cancer." | 1.40 | Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer. ( Chen, XB; Hua, YW; Kong, Y; Liu, HX; Ma, EM; Yang, W; Zhang, B; Zhang, YL; Zhang, ZD, 2014) |
| "We present a case of recurrent gastric cancer in which stable disease status was achieved for four months due to treatment with capecitabine/cisplatin (CDDP)after the failure of multiple anticancer drugs including S-1/CDDP." | 1.40 | [A case of S-1/CDDP-resistant recurrent gastric cancer responsive to capecitabine/CDDP]. ( Sakamoto, K; Sakashita, K; Sawada, R; Sunami, T; Tauchi, J; Yukimoto, K, 2014) |
| "Widespread type 3 gastric cancer was detected in the lesser curvature." | 1.40 | [A case of advanced gastric cancer with multiple liver metastases treated with preoperative TS-1/CDDP chemotherapy and resection, with a complete response and survival for 7 years]. ( Imaida, K; Kagawa, I; Kishi, S; Matsumoto, Y; Mitan, M; Miyamoto, M; Nishiwaki, K; Saoo, K; Tsuda, H; Yokohira, M, 2014) |
| "We report two cases of pancreatic cancer with multiple liver metastases for which successful gemcitabine (GEM) +S-1 therapy facilitated radical resection." | 1.40 | [Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy]. ( Aizawa, M; Nashimoto, A; Nomura, T; Sato, Y; Tsuchiya, Y, 2014) |
| "Gemcitabine plus S-1 was again administered as postoperative adjuvant chemotherapy." | 1.40 | Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case. ( Ide, T; Ide, Y; Kai, K; Kitahara, K; Koga, H; Miyoshi, A; Nakamura, H; Nakamura, J; Noshiro, H; Okumura, T, 2014) |
| "Although there was no progression of gastric cancer, medication of S-1 was discontinued." | 1.40 | [Treatment of repeat TACE plus S-1 for multiple intrahepatic recurrence of hepatoma and gastric cancer]. ( Fujisaki, S; Sakurai, K; Takashina, M; Takayama, T; Tomita, R, 2014) |
| "A 55-year-old man suffering from gastric cancer associated with metastases to the lymph node, gallbladder, and liver was administered chemotherapy with S-1 and cisplatin." | 1.40 | [A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder]. ( Akiyama, Y; Hasuike, Y; Higuchi, I; Miyamoto, M; Tanigawa, T; Yamamoto, M, 2014) |
| "A 71-year-old man was diagnosed with gastric cancer[cT4, cN0, cH1(S6), cP0, cM0, cStage IV]and underwent distal gastrectomy with cholecystectomy, partial colectomy for the invasion to the mesentery of transverse colon, and partial hepatectomy for metastatic liver tumor(segment 6)." | 1.39 | [A case of synchronous liver metastasis originating from advanced gastric cancer treated with combination chemotherapy involving S-1 and surgical intervention]. ( Ohishi, K; Ori, T; Sunayama, K; Takeda, M, 2013) |
| "She was diagnosed as colon cancer with hepatic metastasis." | 1.39 | [A case of metastatic colon cancer effectively treated by XELOX and IRIS]. ( Fujiyama, Y; Kaneko, H; Kikuchi, M; Kinoshita, S; Nishizawa, T; Sakuno, T; Suzuki, H; Takahashi, M, 2013) |
| " Two patients received only SOX as chemotherapy, while the others received SOX in combination with one of the three molecular-targeting agents, bevacizumab, cetuximab, and panitumumab." | 1.39 | Impact of chemotherapy with S-1 and oxaliplatin (SOX) in combination with molecular-targeting agents on colorectal liver metastases. ( Akiba, T; Enomoto, H; Kawahara, H; Toyama, Y; Watanabe, K; Yanaga, K, 2013) |
| "Two patients survived without recurrence for 12 and 21 months." | 1.39 | [Efficacy of combined local therapy especially with hepatic arterial infusion for liver metastasis from gastric cancer]. ( Hasuike, Y; Hirao, S; Ishida, K; Iwagami, Y; Koshino, T; Tomoda, K; Toyomasu, T; Yoshikawa, S, 2013) |
| "A tumor thrombus from the metastatic lesion in the liver jutting out into the umbilical portion of the portal vein was observed." | 1.39 | [Resection of a synchronous liver metastasis from gastric cancer associated with portal vein tumor thrombosis - a case report]. ( Kametaka, H; Koyama, T; Makino, H; Seike, K, 2013) |
| "In June 2010, he underwent sigmoid colon cancer resection, followed by local ablation therapy for the liver tumors( S4, S5, and S6) and hepatic segmentectomy( S3 and S7)." | 1.39 | [Multiple hepatic metastases from colon cancer successfully treated with irinotecan and S-1 plus panitumumab as second-line therapy-a case report]. ( Kwon, AH; Motohiro, T; Nakatake, R; Saito, T; Tanaka, H; Ueda, A; Yamamichi, K, 2013) |
| "He is free of recurrence now without adjuvant chemotherapy four years after repeat hepatectomy." | 1.39 | [A case experienced long-term survival after repeat hepatectomy for liver metastases from gastric cancer]. ( Bando, E; Goto, H; Kawamura, T; Makuuchi, R; Miki, Y; Sugisawa, N; Tanizawa, Y; Terashima, M; Tokunaga, M; Uesaka, K; Yamakawa, Y, 2013) |
| "A 65-year-old male with type 5 gastric cancer and two lesions of liver metastases was initially treated with S-1/CDDP." | 1.38 | [A case of stage IV gastric cancer with multiple liver metastases responding to chemotherapy with weekly PTX after failure of chemotherapy with S-1 and CDDP combination]. ( Higashiyama, M; Kato, T; Nakamura, Y; Nakayama, H; Nobutou, Y; Okamura, R; Wada, S; Yoh, T, 2012) |
| "We experienced two cases of Stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy." | 1.38 | [Two cases of stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy]. ( Azuma, T; Inoue, T; Mori, Y; Ohtani, H; Tamamori, Y, 2012) |
| "A57 years old man with gastric cancer underwent distal gastrectomy (pT3N1M0, pStage II B)." | 1.38 | [A case of pathological complete response after chemotherapy for liver metastasis with subcapsular hemorrhage from gastric cancer:]. ( Aramaki, T; Bando, E; Goto, H; Kanemoto, H; Kawamura, T; Tanizawa, Y; Terashima, M; Tokunaga, M; Uesaka, K; Yasui, H, 2012) |
| "The prognosis for pancreatic cancer with distant metastasis is not good." | 1.38 | [Effective multidisciplinary therapy mainly using S-1+ gemcitabine (GEM) for a case of pancreatic body cancer with multiple liver metastases]. ( Fujioka, M; Fukui, H; Kou, C, 2012) |
| "The patient was diagnosed with hepatocellular carcinoma during work-up for hepatic dysfunction." | 1.38 | [A case of diffuse hepatocellular carcinoma(Vp4) treated by right hepatic trisegmentectomy and multidisciplinary therapy regimens]. ( Kametaka, H; Koyama, T; Makino, H; Seike, K, 2012) |
| "In addition, we found concomitant gastric cancer by gastrointestinal fiberscopy." | 1.38 | [A patient with multiple liver metastases of gastric and rectal cancers after laparoscopic sigmoidectomy who responded completely to S-1 therapy followed by open gastrectomy]. ( Arai, I; Inoue, S; Ohashi, I; Tamura, C; Wakasa, K, 2012) |
| " Adverse events were assessed by the National Cancer Institute Common Terminology Criteria for Adverse Events." | 1.37 | Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study. ( Asaka, M; Hatanaka, K; Hosokawa, A; Iwanaga, I; Kato, T; Komatsu, Y; Kusumi, T; Miyagishima, T; Nakamura, M; Sakata, Y; Sogabe, S; Yuki, S, 2011) |
| " Though grade 3 neutropenia appeared after 2 courses of the combined therapy, the patient well tolerated it after controlling the dosing schedule." | 1.37 | [A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy]. ( Hatata, T; Ikeguchi, M; Kondo, A; Naka, T; Takaya, S; Taniguchi, K, 2011) |
| "Pancreatic acinar cell carcinoma is rare, and its incidence is less than 1% of all the malignant pancreatic tumors." | 1.37 | [A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1]. ( Fukuoka, J; Hosokawa, A; Ishizawa, S; Itaya, Y; Kajiura, S; Kawai, K; Minemura, M; Nakayama, Y; Nishimizu, T; Sawasaki, T; Shimizu, S; Sugiyama, T; Tajiri, K; Takahara, T; Tokimitsu, Y; Yamawaki, H; Yanagisawa, A; Yasumura, S, 2011) |
| "He was an HBV carrier, and hepatocellular carcinoma (HCC) was detected for the first time in 2000." | 1.37 | [Retroperitoneal metastasis of hepatocellular carcinoma - a case report]. ( Kameda, R; Kanazawa, A; Kobayashi, S; Miyakawa, K; Morinaga, S; Ohkawa, S; Tamura, S; Ueno, M; Yamamoto, N, 2011) |
| "We report a case of anal cancer in a 58-year-old woman who complained of narrow, bloody stools and anal pain." | 1.37 | Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer. ( Deguchi, T; Fujisaki, M; Kadomura, T; Kato, A; Kato, Y; Kitajima, M; Kojima, M; Kubota, K; Kuroda, J; Nitori, N; Okada, A; Origuchi, N, 2011) |
| "Patients with severe metastatic pancreatic cancer received chemotherapy comprising S-1 (30mg/m² p." | 1.37 | [Gemcitabine plus S-1 combination therapy (GS therapy) for pancreatic cancer patients with high-grade hepatic metastasis]. ( Asagi, A; Hori, S; Iguchi, H; Ikeda, Y; Kajiwara, T; Matsumoto, T; Nadano, S; Nishina, T; Takeji, S, 2011) |
| "We report a long-term survival case of rectal cancer that was initially thought unresectable treated with chemoradiotherapy (CRT)." | 1.37 | [A case of long-term survival after curative resection of advanced rectal cancer treated by pre-operative chemoradiotherapy]. ( Kamiya, A; Kawachi, Y; Maruyama, H; Nagano, H; Nakajima, Y; Ohtsukasa, S; Okazaki, S; Takamatsu, S, 2011) |
| "A 60-year-old man with intrahepatic cholangiocarcinoma (ICC) underwent a left hepatectomy." | 1.37 | [A case of intrahepatic recurrence of intrahepatic cholangiocarcinoma treated with repeated hepatectomy]. ( Akagi, K; Dono, K; Fujita, J; Hata, T; Ikeda, K; Iwazawa, T; Kawanishi, K; Kitada, M; Miyake, M; Nagai, K; Shimano, T; Shimizu, J, 2011) |
| "A 77-year-old man was diagnosed as hepatocellular carcinoma, and was referred to our hospital." | 1.37 | [A case of complete response to interferon-α and S-1 combination therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection]. ( Doki, Y; Eguchi, H; Katsura, Y; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Tanemura, M; Umeshita, K; Wada, H; Wakasa, K, 2011) |
| "A case of a 68-year-old man with hepatocellular carcinoma (HCC) is presented." | 1.37 | [A case of successful surgical resection followed by S-1 administration for hepatocellular carcinoma with lung metastases and a tumor thrombus into right atrium]. ( Doki, Y; Eguchi, H; Kawamoto, K; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Tanemura, M; Umeshita, K; Wada, H, 2011) |
| "Upper gastroscopy revealed advanced gastric cancer." | 1.36 | [A case of advanced gastric cancer with multiple liver metastases completely responding long term to paclitaxel plus S-1 therapy]. ( Akagi, S; Kanou, M; Kurisu, Y; Tanaka, T; Toge, K, 2010) |
| "The treatment for hepatocellular carcinoma with distant metastasis remains unclear." | 1.36 | [A successful case of S-1 chemotherapy for bilateral pulmonary recurrence of hepatocellular carcinoma long after hepatectomy]. ( Fukumori, D; Kamachi, H; Kamiyama, T; Matsushita, M; Nakanishi, K; Tahara, M; Todo, S; Yokoo, H, 2010) |
| " In view of the side effects such as reduction in appetite and leukocyte, the dosage has been reduced as of the second course of treatment." | 1.36 | [A case of breast cancer with multiple hepatic metastasis successfully treated with S-1/PTX and S-1 chemotherapy]. ( Fujikuni, N; Hashimoto, M; Iwako, H; Kuranishi, F; Kuroda, Y; Moriyuki, T; Niitsu, H, 2010) |
| "CT demonstrated liver(S5/6)and lung(S9)metastases in August 2002." | 1.36 | [A case of long-term survival after undergoing S-1 treatment and splenectomy for liver, lung and splenic metastases following curative distal gastrectomy for gastric cancer]. ( Furuya, T; Hirao, H; Nagai, M; Nakamura, H; Nomura, Y; Ogura, M; Suzuki, Y; Takahashi, M; Takayama, T; Tanaka, N, 2010) |
| "No re-growth of gastric cancer has been seen for 9 months with this chemotherapy." | 1.36 | [A very elderly case of recurrent gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of docetaxel (DOC) and S-1]. ( Hachisuka, T; Hattori, K; Kinoshita, T; Miyauchi, M; Mori, T; Shikano, T; Shinohara, M; Yamamoto, T, 2010) |
| "The prognosis for pancreatic cancer with distant metastases is not good." | 1.36 | [S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis]. ( Fukui, H; Kou, C; Matsumoto, M; Matsumoto, T, 2010) |
| "We encountered a case of AFP-producing gastric cancer that accompanied early gastric cancer and was treated effectively by S-1." | 1.36 | [A case of AFP-producing gastric cancer with hepatic metastases that accompanied early gastric cancer treated effectively by chemotherapy]. ( Amaya, S; Fujisawa, K; Iida, Y; Ishii, H; Koizumi, H; Mitsui, T; Miura, S; Munemoto, Y; Sato, Y; Terada, T, 2010) |
| "A detailed examination revealed a gastric cancer located from antrum to duodenal bulb with multiple liver metastases." | 1.36 | [Long-term survival of patient with gastric cancer treated by S-1 + paclitaxel combination chemotherapy against multiple liver metastases after gastrectomy and adrenalectomy]. ( Ikeda, J; Itokawa, Y; Koide, K; Otsuji, E; Shimizu, H; Shioaki, Y; Sonoda, H; Takashina, K; Taniguchi, F; Ueshima, Y, 2010) |
| "Despite a diagnosis of cStage IV gastric cancer (cN2, cH0, cM0, cT3 (SE), cP1), we preferentially performed a non-curative surgery to avoid stenosis or bleeding by tumor invasion." | 1.36 | [Long-term disease-free survival following multimodal treatment in a patient with curatively unresectable advanced gastric cancer with metachronous liver metastasis]. ( Fukumoto, I; Fukumoto, K; Ishida, E; Itani, K; Kanemitsu, D; Kassai, K; Kobayashi, Y; Miyagaki, T; Nakase, Y; Sakamoto, K; Soga, K; Takagi, T; Takenaka, S; Yanagida, K, 2010) |
| "A 75-year-old man with advanced gastric cancer underwent distal gastrectomy with lymph node dissection(D1)and Roux-en Y reconstruction." | 1.35 | [A case of Stage IV gastric cancer with liver and peritoneal metastases responding completely to tailored S-1/CPT- 11 combination therapy]. ( Arai, H; Kashiwabara, M; Maruyama, H; Matsuda, A; Matsushita, A; Matsutani, T; Miyamoto, M; Mizutani, T; Nishi, Y; Sasajima, K; Suzuki, S; Tajiri, T; Yanagi, K; Yokoyama, T, 2008) |
| "A 65-year-old man with common bile duct cancer was treated by pylorus-preserving pancreaticoduodenectomy with D2 lymph node dissection." | 1.35 | [A case of liver metastatic recurrence of bile duct cancer completely responding to single-drug S-1 chemotherapy]. ( Fukao, K; Irabu, S; Kasagawa, T; Kusashio, K; Matsumoto, M; Nobumoto, D; Suzuki, M; Tashima, Y; Tonooka, T; Udagawa, I; Yasutomi, J, 2008) |
| "Cholangiocarcinoma is a therapeutically challenging malignancy." | 1.35 | Long-term survival after multimodal therapy in a patient demonstrating intrahepatic cholangiocarcinoma with hilar invasion and intrahepatic metastases. ( Akaike, M; Morinaga, S; Shiozawa, M; Sugano, N; Sugimasa, Y; Wada, H; Yamamoto, Y, 2008) |
| "There is no standard treatment for hepatocellular carcinoma (HCC) patients with extrahepatic metastases." | 1.35 | Combination therapy of oral fluoropyrimidine anticancer drug S-1 and interferon alpha for HCC patients with extrahepatic metastases. ( Aikata, H; Azakami, T; Chayama, K; Jeong, SC; Kawakami, Y; Kawaoka, T; Mori, N; Takahashi, S; Takaki, S; Uka, K, 2008) |
| " We treated the patient with S-1 combined with CPT-11." | 1.35 | [Three cases with liver metastasis from gastric or colon cancer successfully treated with S-1 combined with CPT- 11]. ( Ishii, Y; Mado, K; Manmoto, J; Masuda, H; Mazaki, T; Okame, H; Suzuki, K; Takayama, T, 2008) |
| "A type 2 advanced gastric cancer was observed on the gastric antrum." | 1.35 | [A case of early recurrence with multiple liver metastases after curative operation of gastric cancer successfully treated by S-1/CDDP combination chemotherapy]. ( Akiho, H; Goto, A; Itaba, S; Murao, H; Nagai, E; Nakamura, K; Segawa, Y; Takayanagi, R; Tokunaga, N; Yoshinaga, S, 2008) |
| "We report a successful case of chemotherapy accompanied with grade 4 adverse events for unresectable advanced gastric cancer." | 1.35 | [A case of unresectable advanced gastric cancer successfully treated with continuous S-1 + CPT-11 chemotherapy accompanied by dose reduction against grade 4 hematological adverse event]. ( Furukawa, H; Imamura, H; Kishimoto, T; Miyazaki, Y; Ota, K; Tatsuta, M, 2008) |
| "A 60-year-old man diagnosed as advanced sigmoid colon cancer was performed sigmoidectomy and D3 lymph node dissection." | 1.35 | [A case of advanced sigmoid colon cancer performed resection of liver metastases after long-term control by S-1 and CPT-11 combination chemotherapy]. ( Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Suzuki, R; Tamura, S; Uji, K; Yoshida, A; Yoshimura, M, 2008) |
| "A 82-year-old man with advanced gastric cancer underwent distal gastrectomy in January 2006." | 1.35 | [Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer]. ( Kitajima, Y; Miyazaki, K; Nakafusa, Y; Ohtsuka, T; Sato, S; Tanaka, M; Yakabe, T, 2009) |
| "Abdominal CT scan revealed pancreatic cancer with massive ascites showing peritoneal dissemination, combined with lymph node and liver metastases." | 1.35 | [A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases]. ( Fushida, S; Kimura, H; Mukawa, A, 2009) |
| "Though chronic hepatitis C was pointed out before, it had been left untreated for about 5 years." | 1.35 | [A case of advanced hepatocarcinoma responding to combination therapy of S-1 and PEG-IFN]. ( Ichikawa, M; Iwakawa, K; Matsumoto, T; Miyauchi, S; Seike, H; Tanaka, Y; Tanisaka, Y; Tsubouchi, E, 2009) |
| "We experienced this AFP-producing gastric cancer in which CR was possible by FLEP." | 1.35 | [Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case]. ( Fujii, M; Funada, T; Kaiga, T; Kanamori, N; Kochi, M; Takahashi, T; Takayama, T, 2009) |
| "A 66-year-old man was diagnosed with hepatocellular carcinoma with Vp3 by abdominal enhanced CT." | 1.35 | [A case of successful multimodal treatment for combined hepatocellular and cholangiocarcinoma with portal venous tumor thrombus]. ( Doki, Y; Eguchi, H; Hatano, H; Kobayashi, S; Marubashi, S; Mori, M; Murakami, M; Nagano, H; Takeda, Y; Tanemura, M; Tomimaru, Y; Tomokuni, A; Wakasa, K, 2009) |
| "We report a long-term survival case of pancreatic cancer with hepatic metastasis after surgical resection treated by S-1 and gemcitabine combination chemotherapy." | 1.35 | [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy]. ( Doki, Y; Eguchi, H; Hoshino, H; Kitagawa, T; Kobayashi, S; Marubashi, S; Monden, M; Mori, M; Nagano, H; Nakamori, S; Takeda, Y; Tanemura, M; Umeshita, K, 2009) |
| "After examination, she was diagnosed as sigmoid colon cancer with multiple liver metastases." | 1.35 | [A case of sigmoid colon cancer with multiple liver metastases responding to S-1]. ( Hara, K; Maruyama, T; Ohkohchi, N; Takagaki, T, 2008) |
| "Grade 3 leukocytopenia was observed in 1 patient (8." | 1.35 | Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis. ( Dono, K; Kobayashi, S; Marubashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamura, M; Noda, T; Takeda, Y; Umeshita, K; Wada, H, 2008) |
| "All of the 9 gastric cancer cases were diagnosed as being resectable other than ones with metastases to the liver, or a primary tumor resection was performed on the cases." | 1.35 | [Therapeutic experience of S-1 plus other drug combination therapy for synchronia multiple liver metastases of gastric cancer]. ( Imaizumi, T; Kizaki, J; Koga, A; Miyagi, M; Shirouzu, K; Yano, S, 2008) |
| "Advanced hepatocellular carcinoma (HCC) with distant metastases, in particular to the lung, has a poor prognosis." | 1.34 | [Retrospective analysis of clinical results in eight patients with advanced hepatocellular carcinoma with lung metastases treated by TS-1]. ( Asechi, H; Hatano, E; Ikai, I; Nagata, H; Narita, M; Uemoto, S; Yanagida, A; Yasuchika, K, 2007) |
| "No re-growth of gastric cancer has been seen for three years with chemotherapy of TS-1." | 1.34 | [A case of advanced gastric cancer with liver metastases successfully treated by combination therapy of TS-1 and docetaxel]. ( Ichinari, H; Kawano, F; Matsuda, S; Mine, K; Taneda, Y; Yonei, A, 2007) |
| " As for the dosing method of combination chemotherapy,the patient was treated with a course of TS-1 80 mg daily divided into two doses over 21 days continuously, followed by a 14-day cessation of the drug,together with a dose of CDDP 70 mg on day 8." | 1.34 | [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases]. ( Hayakawa, Y; Hioki, J; Irinoda, T; Kimura, T; Kobayashi, M; Matsumoto, Y; Meguro, E; Noda, Y; Takagane, A, 2007) |
| "The patient was diagnosed as advanced gastric cancer (type-3) with multiple liver metastasis and obstructive jaundice." | 1.34 | [A case of advanced gastric cancer with obstructive jaundice due to multiple liver metastasis successfully treated with the following combination therapy of CPT-11 and cisplatin after combination therapy of paclitaxel and TS-1]. ( Funada, R; Harada, K; Hasegawa, K; Homma, N; Ogata, N; Shibasaki, K; Soga, K; Uchida, M; Watanabe, T, 2007) |
| "A 37-year-old female with advanced gastric cancer and liver metastases was treated with S-1." | 1.34 | A case of suspected S-1 induced interstitial pneumonia. ( Koizumi, W; Munakata, M; Sakata, Y; Shitara, K, 2007) |
| "A 62-year-old woman with Barrett's esophageal cancer was hospitalized." | 1.34 | Successful treatment of S-1 + CDDP followed by salvage EMR for a case with metastatic Barrett's esophageal cancer. ( Azuma, M; Higuchi, K; Katada, C; Koizumi, W; Nakatani, K; Nishimura, K; Saigenji, K; Sasaki, T; Shimoda, T; Tanabe, S, 2007) |
| "A distal gastrectomy for advanced gastric cancer with liver metastasis was performed on a 71-year-old male." | 1.34 | [A case of liver metastasis of gastric cancer undergoing non-curative operation responding completely to combination therapy of S-1 and CDDP]. ( Aoki, T; Mino, A; Murahashi, K; Nishino, K; Sowa, M; Tachimori, A; Takagaki, K, 2007) |
| " This article identifies the risk factors for severe adverse events of S-1 from nationwide survey data." | 1.34 | Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer. ( Fukushima, M; Ishiwata, R; Matsumoto, S; Nagai, Y; Teramukai, S; Yamanaka, T, 2007) |
| "We treated hepatic metastasis of gastric cancer with CPT-11 therapy and obtained complete remission of the hepatic tumor that has been maintained for than 2 years postoperatively." | 1.34 | [Complete remission of hepatic metastasis of gastric cancer with CPT-11]. ( Kohno, H; Ogawa, A; Okajima, A; Taguchi, T; Takenouchi, Y; Tsugane, K, 2007) |
| " Since a curative operation is impossible in this case, we started systemic chemotherapy employing S-1 combined with hepatic arterial infusion using epirubicin hydrochloride and mitomycin C." | 1.34 | [A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion]. ( Ishiguro, A; Itoh, J; Munakata, A; Munakata, M; Sakata, Y; Shitara, K; Suzuki, K; Takahata, T, 2007) |
| "We report a case of advanced gastric cancer with multiple liver metastases,in which a complete resection was performed following a bypass operation and chemotherapy." | 1.34 | [Complete resection of advanced gastric cancer with multiple liver metastases following a bypass operation and one year of chemotherapy]. ( Hatakeyama, K; Kobayashi, T; Kurosaki, I; Kurosaki, R; Matsuo, H; Ohashi, M; Yajima, K, 2007) |
| "We experienced a case of advanced gallbladder cancer with a remarkable response treated by oral fluoropyrimidine anticancer drug S-1 (120 mg/day on day 1 through 28 followed by a 14-day recovery period) as first-line chemotherapy." | 1.34 | [A case report of S-1 monotherapy as first-line treatment for metastatic gallbladder cancer]. ( Amano, A; Ohkawa, S; Ueno, M, 2007) |
| "We report 2 cases of advanced gastric cancer with synchronous liver metastases who were successfully downstaged using S-1 plus low-dose cisplatin chemotherapy followed by surgical resection." | 1.34 | Successful preoperative chemotherapy with S-1 plus low-dose cisplatin for advanced gastric cancer with synchronous liver metastases: report of 2 cases. ( Aiba, K; Aoki, H; Kashiwagi, H; Koyama, T; Mitsumori, N; Nimura, H; Takahashi, N; Yanaga, K, 2007) |
| "4 patients with hepatocellular carcinoma (HCC) and 3 with cholangiocellular carcinoma (CCC) were employed for this study." | 1.34 | S-1 plus cisplatin combination therapy for the patients with primary liver carcinomas. ( Fujita, J; Hoshimoto, S; Ikeda, M; Kato, T; Morise, Z; Sugioka, A, 2007) |
| "Case 1: 66-year-old male with advanced gastric cancer invading the pancreas with metastasis to the liver and left neck lymph nodes." | 1.33 | [Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1]. ( Hamai, Y; Hihara, J; Ohta, K; Suzuki, T; Tanabe, K; Taomoto, J; Toge, T; Yoshida, K, 2005) |
| "The prognosis of liver metastasis of gastric cancer is generally poor, and there is no comprehensive therapy." | 1.33 | [A case of gastric cancer with liver metastasis resected after the combination chemotherapy with CDDP and TS-1]. ( Amano, M; Hayashida, H; Higaki, N; Itani, Y; Nakagawa, S; Niinobu, T; Nishikawa, Y; Sakon, M, 2005) |
| "These results suggest that gastric cancer,in which liver metastasis is considered to be a prognostic factor,can be effectively treated by combination therapy with hepatic arterial infusion therapy, followed by thermochemotherapy for the primary lesion." | 1.33 | [A case of gastric cancer with multiple liver metastases effectively treated by hepatic arterial infusion of MMC, TS-1/CDDP therapy, and thermotherapy]. ( Aoki, T; Hamaya, M; Kouno, T; Nishida, J; Ogata, T; Sato, S; Seo, K; Tsuchida, A; Yoshida, K, 2005) |
| " Because salvage therapy with S-1 alone showed good antitumor efficacy and beneficial tolerability when the standard dosage was maintained, it was considered that this home therapy was effective for advanced/recurrent breast cancer that was resistant to anthracycline and taxane antitumor drugs." | 1.33 | [Effective salvage chemotherapy with S-1 alone in a patient with lung metastasis of breast cancer]. ( Itoh, K; Minami, H, 2005) |
| "The patient, who had unresectable colon cancer metastases to the liver and lung, was referred to us for chemotherapy from an affiliated hospital; he had no cardiac history." | 1.33 | 5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine. ( Hatakeyama, K; Muneoka, K; Shirai, Y; Wakai, T; Yokoyama, N, 2005) |
| "Three cases with unresectable advanced gastric cancer with liver metastases were successfully treated by the combination therapy of TS-1 and cisplatin( CDDP)." | 1.33 | [Three advanced gastric cancer cases with liver metastases successfully treated by TS-1/CDDP combination therapy]. ( Goto, H; Ina, K; Inagaki, J; Ito, A; Ito, N; Kataoka, T; Matsui, W; Nagao, S, 2006) |
| "We experienced a case of recurrent breast cancer resistant to prior medications, which was treated with oral S-1, a fluoropyrimidine-class anticancer drug, and exhibited the marked shrinkage of liver metastasis." | 1.33 | [A case of liver metastasis successfully treated with S-1 monotherapy in the patient with recurrent breast cancer]. ( Mitsuyama, S; Nishihara, K, 2006) |
| "Pancreatic acinar cell carcinomas are rare, and little is reported on their chemotherapy." | 1.33 | [Pancreatic acinar cell carcinoma successfully treated with combination of oral TS-1 and intra-arterial cisplatin]. ( Endo, S; Hashimoto, K; Higami, T; Itagaki, T; Itakura, M; Kataoka, Y; Koike, M; Nio, Y; Nishi, T; Yano, S, 2006) |
| "The patient diagnosed as recurrent pancreatic cancer was treated with UFT combined gemcitabine (GEM) chemotherapy." | 1.33 | [A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease]. ( Kagaya, T; Kaneko, S; Kato, Y; Sunagozaka, H; Yamashita, T, 2006) |
| "We report a rare patient with a DPD deficiency." | 1.33 | [A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency]. ( Arai, K; Hashimoto, T; Hiruma, K; Iwasaki, Y; Matsumoto, H; Saze, Z; Takahashi, K; Yamaguchi, T; Yamashita, Y; Yasutome, M, 2006) |
| " We carried out 4-week administration of 80-120 mg/day of TS-1 according to body surface area, followed by a 2-week discontinuation, then repeated administration which adjusting the dosage according to the incidence of side effects, and discussed the antitumor effects and adverse events." | 1.33 | [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer]. ( Hatori, S; Imada, T; Kunisaki, C; Makino, T; Ohshima, T; Rino, Y; Suda, T; Takanashi, Y; Yamada, R; Yamazaki, Y, 2006) |
| "At laparotomy to improve anemia and pyloric stenosis in September 2001, lymphnode metastases invaded the stomach and the pancreatic body." | 1.33 | [A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months]. ( Ishizuka, D; Kobayashi, K; Tada, T; Ueki, K; Wakakuwa, R, 2006) |
| "Gastrofiber-scopy revealed that type 3 gastric cancer was widespread in the lesser curvature." | 1.33 | [A resected case of advanced gastric cancer with multiple liver metastasis responding to preoperative TS-1/CDDP chemotherapy]. ( Kagawa, I; Matsumoto, Y; Nishiwaki, K; Ohi, A, 2006) |
| "In two patients with advanced pancreatic cancer with cervical lymph node or liver metastasis and no indication of pancreatic resection and radiotherapy, oral treatment with S-1 (an anti-cancer agent of fluoropyrimidine derivative) exerted high anti-tumor activity on the metastatic lesions." | 1.33 | [Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy]. ( Funakoshi, A; Senju, T; Sumii, T, 2006) |
| "We report two metastatic pancreatic cancer patients who showed marked tumor shrinkage following administration of the oral fluorinated pyrimidine anticancer drug, S-1." | 1.33 | [Two patients effectively treated by S-1 monotherapy for metastatic pancreatic cancer]. ( Ikeda, M; Ueno, H, 2006) |
| "Grade 3 neutropenia was observed, but no other severe toxicities were noted." | 1.33 | [Chemotherapy-naïve advanced pancreatic cancer with multiple liver metastases successfully treated by S-1 monotherapy--a case report]. ( Boku, N; Fukutomi, A; Yoshino, T, 2006) |
| "Paclitaxel was administered to 4 patients at a weekly dose of 80 mg/m2/day for three weeks followed by a one week interval." | 1.32 | [Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1]. ( Chida, N; Imai, G; Ishibashi, J; Iwabuchi, M; Matsuda, Y; Mochida, A; Shiina, M; Suzuki, S; Suzuki, T; Tadokoro, K; Takahashi, H; Yamada, K; Yokoyama, H, 2003) |
| "The prognosis and QOL of unresectable pancreatic cancer are very poor." | 1.32 | [A case of advanced pancreatic cancer with multiple liver metastasis that improved remarkably with use of low-dose cisplatin and TS-1]. ( Endo, W; Fujito, T; Goda, F; Hojo, S; Maeura, Y; Matsuyama, J; Yamazaki, K; Yano, Y, 2003) |
| "S-1 appears to be safe and highly active, with favorable longterm survival in patients with metastatic gastric cancer, particularly in those with diffuse-type histology and peritoneal metastasis." | 1.32 | Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey. ( Boku, N; Doi, T; Hamamoto, Y; Kawai, H; Mera, K; Muto, M; Nagashima, F; Ohtsu, A; Sano, Y; Yano, T; Yoshida, S, 2003) |
| "The patient was diagnosed with advanced gastric cancer (type-3) with lymphangitis carcinomatosa of the lung." | 1.32 | [A case of advanced gastric cancer with lymphangitis carcinomatosa of the lung, successfully treated with paclitaxel and TS-1]. ( Kawabata, H; Murata, A; Nakajima, H; Takase, I; Watanabe, T, 2003) |
| "The upper endoscopy revealed advanced gastric cancer." | 1.32 | [A case of advanced gastric cancer with multiple liver metastases responding to TS-1 and CDDP]. ( Akaiwa, J; Kondo, Y; Makuuchi, H; Morita, M; Nabeshima, K; Nakamura, K; Nishi, T; Ogoshi, K; Okamoto, Y; Soeda, J; Tajima, T, 2003) |
| "We report a case of advanced gastric cancer with antral stenosis that responded to an oral anticancer agent, TS-1, after metallic stent insertion." | 1.32 | [A case of malignant gastric outlet stenosis palliated with self-expandable metallic stent and responding to TS-1, an oral fluorouracil derivative]. ( Matsuura, T; Mitsugi, K; Nagano, C; Seo, M; Tokumitsu, Y, 2004) |
| "A standard treatment for hepatocellular carcinoma with extrahepatic metastasis is not established and chemotherapy is ineffective." | 1.32 | [A case of hepatocellular carcinoma with bone metastasis responding to concurrent TS-1/low-dose cisplatin (CDDP) therapy and radiotherapy]. ( Aozasa, S; Fujino, K; Hase, K; Ito, H; Okada, K; Shikina, A; Suganuma, T; Tanaka, M; Terauchi, R; Tsuda, T; Utsunomiya, K, 2004) |
| " S-1 has safe and potent antitumor effects in patients with gastric cancer via these respective functions." | 1.32 | Safety and efficacy of S-1, a novel oral fluorouracil antitumor drug, for a chronic renal failure patient maintained on hemodialysis. ( Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Matsumoto, T; Okazaki, H; Oshitani, N; Sasaki, E; Shiba, M; Suto, R; Tanigawa, T; Tominaga, K; Watanabe, T, 2004) |
| "The prognosis of gastric cancer with liver metastasis is very poor." | 1.32 | [Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion]. ( Aoyagi, K; Imaizumi, T; Koufuji, K; Miyagi, M; Shirouzu, K; Takeda, J; Yano, S, 2004) |
| "Docetaxel will be a key drug for the gastric cancer." | 1.32 | [A case report of the 8 year survivor--unresectable liver metastases from advanced gastric cancer (Stage IV) were completely responsive, after 4 years from a total sequential gastrectomy, combining docetaxel treatment to regress the recurrence]. ( Handa, R; Iijima, S; Kato, T; Kikkawa, N; Kurokawa, E; Naoi, Y; Ohshima, S; Tsujie, M; Yamamoto, H, 2004) |
| "Case 1: A 67-year-old male with gastric cancer." | 1.32 | [Three successful case reports of advanced gastric cancer with chemotherapy]. ( Fukunaga, K; Kawai, M; Kotobuki, T; Niinobu, T; Taniguchi, H; Yamamoto, M, 2004) |
| "Lentinan was administered at 2 mg/week." | 1.32 | [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer]. ( Andou, K; Hibi, T; Kurosawa, Y; Nagahashi, S; Nishiwaki, M; Okuda, K; Sugihara, T; Suzuki, H; Terada, S, 2004) |
| "A Case of Advanced Gastric Cancer with Multiple Liver Metastases Successfully Treated with TS-1 and CDDP: Akihiro Tsukahara, Kazuhiro Kaneko and Syuji Tanaka (Dept." | 1.32 | [A case of advanced gastric cancer with multiple liver metastases successfully treated with TS-1 and CDDP]. ( Kaneko, K; Tanaka, S; Tsukahara, A, 2004) |
| "We report a case of inoperable gastric cancer with multiple liver metastases, which responded significantly to the short-term administration of TS-1 following intravenous FMP therapy." | 1.31 | [Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization]. ( Chinzei, T; Okada, Y; Tasaka, K; Tomofuji, Y, 2002) |
| "We encountered a patient with gastric cancer for whom oral administration of S-1 was effective, and we report this case." | 1.31 | Advanced gastric cancer with liver metastases successfully treated with S-1. ( Hirayama, Y; Takabayashi, H; Takeuchi, T; Tanaka, T; Watanabe, S, 2002) |
| "We report a case of advanced gastric cancer producing Alpha Fetoprotein (AFP) with multiple liver metastases in which TS-1 is effective." | 1.31 | [A case of advanced gastric cancer producing alpha fetoprotein with multiple liver metastases responding to TS-1 after TAE]. ( Hayashi, Y; Kawasaki, Y; Kobayakawa, K; Ohtsuru, M; Oka, H; Okazaki, M; Yamamura, J; Yamamura, M; Yasuda, S, 2001) |
| "We present the case of a 72-year-old man with gastric tube cancer accompanied by multiple liver metastases, after esophagectomy for esophageal cancer, whose quality of life (QOL) was improved with a small dosage of TS-1." | 1.31 | [A patient with advanced gastric cancer in the gastric tube whose QOL was improved by TS-1]. ( Ajisaka, H; Fujita, H; Inokuchi, M; Iwata, K; Kaji, M; Konishi, K; Maeda, K; Miwa, A; Yabushita, K; Yamamoto, S; Yoshioka, I, 2002) |
| "We report three patients with recurrent gastric cancer responding to TS-1 therapy after combination chemotherapy with 5-fluorouracil, mitomycin C and cisplatin." | 1.31 | [Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin]. ( Hayashi, K; Iijima, S; Koyama, Y; Miyazawa, K; Morikawa, A; Murakami, M; Okabe, R; Ozaki, K; Sugiyama, A; Suzuki, A, 2002) |
| "The therapeutic effect of S-1 on human colon cancer xenografts (TK-13) with high metastatic potential to the liver was evaluated." | 1.30 | Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) on liver metastasis of xenotransplanted human colon carcinoma. ( Baba, M; Kamiya, K; Kanai, T; Konno, H; Matsumoto, K; Nakamura, S; Tanaka, T, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.26) | 18.2507 |
| 2000's | 176 (45.48) | 29.6817 |
| 2010's | 203 (52.45) | 24.3611 |
| 2020's | 7 (1.81) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, H | 1 |
| Ito, S | 1 |
| Kawaguchi, K | 1 |
| Isobe, H | 1 |
| Urayama, M | 1 |
| Fuse, A | 1 |
| Ota, K | 2 |
| Hokkoku, D | 2 |
| Akamaru, Y | 2 |
| Wada, N | 2 |
| Wada, R | 3 |
| Ikeshima, R | 2 |
| Munakata, K | 2 |
| Takiuchi, D | 3 |
| Morimoto, O | 2 |
| Ota, H | 5 |
| Shibata, K | 2 |
| Ohash, H | 1 |
| Kataoka, N | 1 |
| Hiramatsu, S | 1 |
| Yasuda, K | 1 |
| Kashu, N | 1 |
| Yoshitake, H | 1 |
| Takami, T | 1 |
| Yamaguchi, T | 6 |
| Tomita, M | 1 |
| Shono, Y | 1 |
| Makimoto, S | 1 |
| Tamesa, T | 1 |
| Saeki, S | 1 |
| Nishida, Y | 1 |
| Nabeya, M | 1 |
| Tokunou, K | 1 |
| Kawaoka, T | 3 |
| Miyahara, M | 1 |
| Sasaki, S | 1 |
| Yamashita, Y | 3 |
| Kubo, H | 1 |
| Yamamoto, S | 2 |
| Zhou, L | 1 |
| Lin, J | 1 |
| Wu, G | 1 |
| Chen, J | 2 |
| Huang, X | 1 |
| Zhang, S | 1 |
| Kobayashi, T | 4 |
| Mizuno, S | 3 |
| Matsuba, H | 1 |
| Kanamori, M | 1 |
| Maruyama, S | 1 |
| Tamauchi, T | 1 |
| Tohyama, T | 1 |
| Sakamoto, K | 3 |
| Tamura, K | 1 |
| Nakamura, T | 2 |
| Watanabe, J | 4 |
| Wakisaka, H | 1 |
| Takada, Y | 1 |
| Fujita, T | 1 |
| Shimizu, Y | 2 |
| Dongping, F | 1 |
| Yamamoto, N | 5 |
| Kobayashi, M | 5 |
| Iwabu, H | 1 |
| Tsuji, A | 2 |
| Yan, X | 1 |
| Ning, ZY | 1 |
| Wang, P | 1 |
| Zhuang, LP | 1 |
| Xu, LT | 1 |
| Zhu, ZF | 1 |
| Sheng, J | 1 |
| Shen, YH | 1 |
| Hua, YQ | 1 |
| Meng, ZQ | 1 |
| Eguchi, S | 2 |
| Watanabe, Y | 2 |
| Shiobara, M | 2 |
| Wakatsuki, K | 2 |
| Suda, K | 2 |
| Miyazawa, K | 3 |
| Miyoshi, T | 1 |
| Aida, T | 1 |
| Yoneura, N | 1 |
| Yoshioka, S | 4 |
| Yamazaki, K | 5 |
| Mukai, T | 1 |
| Uehara, K | 4 |
| Goto, H | 12 |
| Hiramatsu, K | 3 |
| Kobayashi, S | 14 |
| Sakamoto, E | 3 |
| Maeda, A | 3 |
| Takeuchi, E | 3 |
| Okada, Y | 3 |
| Ebata, T | 2 |
| Nagino, M | 5 |
| Matsuda, K | 1 |
| Namiki, T | 1 |
| Ueno, M | 5 |
| Hashimoto, T | 3 |
| Hanafusa, T | 1 |
| Yokozeki, H | 1 |
| Sato, K | 1 |
| Akiyama, H | 1 |
| Kogure, Y | 1 |
| Suwa, Y | 1 |
| Momiyama, M | 1 |
| Ishibe, A | 1 |
| Endo, I | 2 |
| Saito, H | 3 |
| Fushida, S | 5 |
| Miyashita, T | 3 |
| Oyama, K | 4 |
| Tsukada, T | 2 |
| Kinoshita, J | 3 |
| Tajima, H | 3 |
| Ninomiya, I | 3 |
| Ohta, T | 5 |
| Kudo, M | 4 |
| Moriguchi, M | 1 |
| Numata, K | 1 |
| Hidaka, H | 2 |
| Tanaka, H | 7 |
| Ikeda, M | 7 |
| Kawazoe, S | 1 |
| Ohkawa, S | 4 |
| Sato, Y | 5 |
| Kaneko, S | 6 |
| Furuse, J | 4 |
| Takeuchi, M | 3 |
| Fang, X | 1 |
| Date, Y | 1 |
| Okusaka, T | 5 |
| Yoshizawa, J | 1 |
| Ishizone, S | 2 |
| Ikeyama, M | 1 |
| Nakayama, J | 2 |
| Nomura, H | 1 |
| Okamura, M | 1 |
| Sumii, A | 1 |
| Tsuboi, K | 1 |
| Mizukami, Y | 1 |
| Ota, S | 1 |
| Adachi, Y | 1 |
| Das, K | 1 |
| Taguri, M | 1 |
| Imamura, H | 9 |
| Sugimoto, N | 2 |
| Nishikawa, K | 2 |
| Yoshida, K | 6 |
| Tan, P | 1 |
| Tsuburaya, A | 3 |
| Kabashima, A | 2 |
| Kimura, K | 4 |
| Sanefuji, K | 1 |
| Maekawa, S | 1 |
| Ebisui, C | 2 |
| Hamano, R | 1 |
| Minoji, T | 1 |
| Kitahara, T | 1 |
| Yanagisawa, T | 2 |
| Okamura, S | 4 |
| Fukuchi, N | 1 |
| Murata, K | 1 |
| Yokouchi, H | 2 |
| Kinuta, M | 2 |
| Ohishi, K | 2 |
| Namikawa, T | 1 |
| Kawanishi, Y | 1 |
| Fujieda, Y | 1 |
| Fujisawa, K | 3 |
| Munekage, E | 1 |
| Munekage, M | 1 |
| Maeda, H | 1 |
| Kitagawa, H | 3 |
| Hanazaki, K | 1 |
| Miura, S | 4 |
| Ueda, N | 3 |
| Fujita, H | 3 |
| Kinami, S | 1 |
| Nakano, Y | 2 |
| Kosaka, T | 2 |
| Sakata, N | 2 |
| Nishino, R | 1 |
| Okano, N | 1 |
| Kasuga, A | 1 |
| Kawai, K | 3 |
| Yamauchi, Y | 1 |
| Naruge, D | 1 |
| Nagashima, F | 2 |
| Enomoto, T | 1 |
| Mikami, S | 1 |
| Kitajima, M | 4 |
| Hiwatari, M | 1 |
| Ono, T | 1 |
| Sasaki, N | 1 |
| Saji, O | 1 |
| Matsushita, T | 1 |
| Koizumi, S | 1 |
| Ariizumi, Y | 1 |
| Nakajima, T | 2 |
| Otsubo, T | 1 |
| Tatsubayashi, T | 1 |
| Tanishima, H | 1 |
| Iwakura, S | 1 |
| Tominaga, T | 1 |
| Kimura, M | 2 |
| Horiuchi, T | 1 |
| Hoshida, Y | 1 |
| Yokota, Y | 1 |
| Nagase, H | 1 |
| Noguchi, K | 1 |
| Hamabe, A | 1 |
| Hirota, M | 3 |
| Oshima, K | 1 |
| Tanida, T | 1 |
| Tomimaru, Y | 3 |
| Kawase, T | 2 |
| Morita, S | 2 |
| Iwazawa, T | 3 |
| Akagi, K | 2 |
| Dono, K | 9 |
| Shindo, Y | 1 |
| Fukuda, S | 3 |
| Kataoka, R | 1 |
| Kuwamoto, N | 1 |
| Takaishi, H | 1 |
| Miura, Y | 1 |
| Hirayama, R | 1 |
| Otsuka, R | 1 |
| Saito, S | 1 |
| Fujita, R | 1 |
| Komiyama, S | 1 |
| Izumiya, Y | 1 |
| Kimura, Y | 5 |
| Nakashima, S | 1 |
| Kin, S | 1 |
| Kawakami, S | 1 |
| Zhang, XZ | 1 |
| Tu, JJ | 1 |
| Chen, W | 1 |
| Ma, T | 1 |
| Bai, XL | 1 |
| Liang, TB | 1 |
| Tominaga, K | 2 |
| Kurumiya, Y | 1 |
| Sekoguchi, E | 1 |
| Kiriyama, M | 1 |
| Tago, T | 1 |
| Suzuki, K | 3 |
| Nishida, K | 1 |
| Maruyama, T | 2 |
| Shimazaki, J | 1 |
| Shimoda, M | 1 |
| Suzuki, S | 5 |
| Kou, K | 1 |
| Morishita, Y | 1 |
| Yoshida, N | 1 |
| Kanno, A | 1 |
| Masamune, A | 1 |
| Nabeshima, T | 1 |
| Hongo, S | 1 |
| Takikawa, T | 1 |
| Hamada, S | 2 |
| Kikuta, K | 1 |
| Kume, K | 1 |
| Shimosegawa, T | 1 |
| Saito, K | 3 |
| Isayama, H | 2 |
| Nakai, Y | 2 |
| Takahara, N | 2 |
| Ishigaki, K | 1 |
| Takeda, T | 1 |
| Hakuta, R | 1 |
| Saito, T | 3 |
| Uchino, R | 2 |
| Kishikawa, T | 1 |
| Hamada, T | 3 |
| Sasaki, T | 4 |
| Kogure, H | 2 |
| Matsubara, S | 1 |
| Ijichi, H | 2 |
| Tateishi, K | 2 |
| Tada, M | 2 |
| Koike, K | 3 |
| Yang, H | 1 |
| Sui, Y | 1 |
| Guo, X | 1 |
| Tan, X | 1 |
| Li, Y | 2 |
| Wang, M | 1 |
| Akiyama, N | 1 |
| Karayama, M | 1 |
| Inui, N | 1 |
| Yasui, H | 5 |
| Hozumi, H | 1 |
| Suzuki, Y | 3 |
| Furuhashi, K | 1 |
| Fujisawa, T | 1 |
| Enomoto, N | 1 |
| Nakamura, Y | 2 |
| Inami, N | 1 |
| Matsuura, S | 1 |
| Kaida, Y | 2 |
| Uto, T | 1 |
| Matsui, T | 2 |
| Asada, K | 1 |
| Matsuda, H | 1 |
| Fujii, M | 6 |
| Toyoshima, M | 1 |
| Suda, T | 2 |
| Takahashi, R | 1 |
| Ohashi, M | 5 |
| Kano, Y | 1 |
| Ida, S | 1 |
| Kumagai, K | 2 |
| Nunobe, S | 2 |
| Chin, K | 2 |
| Yamaguchi, K | 2 |
| Sano, T | 1 |
| Hiki, N | 1 |
| Kawada, J | 2 |
| Nishino, M | 2 |
| Hata, M | 2 |
| Tanizaki, K | 2 |
| Ogino, T | 1 |
| Hoshino, H | 2 |
| Okano, M | 2 |
| Nagai, K | 4 |
| Kim, Y | 2 |
| Okuyama, M | 3 |
| Tsujinaka, T | 2 |
| Imamoto, H | 2 |
| Mukai, Y | 1 |
| Matsuyama, R | 1 |
| Koike, I | 1 |
| Kumamoto, T | 2 |
| Kaizu, H | 1 |
| Homma, Y | 1 |
| Takano, S | 1 |
| Sawada, Y | 1 |
| Sugiura, M | 1 |
| Yabushita, Y | 1 |
| Ito, E | 1 |
| Sato, M | 1 |
| Zhai, JM | 1 |
| Yin, XY | 1 |
| Lai, YR | 1 |
| Hou, X | 1 |
| Cai, JP | 1 |
| Hao, XY | 1 |
| Liang, LJ | 1 |
| Zhang, LJ | 1 |
| Yoshida, Y | 2 |
| Sugawara, N | 1 |
| Minami, T | 1 |
| Iwata, N | 1 |
| Ikeda, K | 2 |
| Endoh, T | 1 |
| Sasano, H | 1 |
| Neki, K | 1 |
| Kawahara, H | 4 |
| Watanabe, K | 4 |
| Toyama, Y | 3 |
| Akiba, T | 4 |
| Yanaga, K | 7 |
| Chen, L | 1 |
| Song, MQ | 1 |
| Lin, HZ | 1 |
| Hao, LH | 1 |
| Jiang, XJ | 1 |
| Li, ZY | 2 |
| Chen, YX | 1 |
| Takeda, M | 1 |
| Ori, T | 1 |
| Sunayama, K | 1 |
| Okazaki, M | 2 |
| Okazaki, A | 1 |
| Sato, F | 1 |
| Yamagishi, H | 1 |
| Nishizawa, T | 1 |
| Kinoshita, S | 1 |
| Sakuno, T | 1 |
| Fujiyama, Y | 1 |
| Kikuchi, M | 1 |
| Kaneko, H | 4 |
| Suzuki, H | 2 |
| Takahashi, M | 7 |
| Kitahara, H | 1 |
| Oki, E | 2 |
| Saeki, H | 2 |
| Ando, K | 2 |
| Shirabe, K | 2 |
| Kounoe, S | 1 |
| Aishima, S | 1 |
| Kakeji, Y | 3 |
| Maehara, Y | 3 |
| Miyabayashi, K | 1 |
| Sasahira, N | 1 |
| Hirano, K | 1 |
| Enomoto, H | 3 |
| Ishida, K | 2 |
| Hasuike, Y | 2 |
| Iwagami, Y | 1 |
| Toyomasu, T | 1 |
| Yoshikawa, S | 1 |
| Hirao, S | 1 |
| Koshino, T | 1 |
| Tomoda, K | 1 |
| Makino, H | 2 |
| Kametaka, H | 2 |
| Seike, K | 2 |
| Koyama, T | 3 |
| Nakatake, R | 1 |
| Yamamichi, K | 1 |
| Ueda, A | 1 |
| Motohiro, T | 1 |
| Kwon, AH | 1 |
| Kondo, J | 1 |
| Nisimura, T | 1 |
| Nagashima, Y | 1 |
| Okada, T | 1 |
| Nakamura, M | 7 |
| Setoguchi, M | 1 |
| Yoshino, S | 1 |
| Sakata, K | 1 |
| Omura, N | 1 |
| Fukuoka, M | 1 |
| Tachibana, S | 1 |
| Yoshimura, H | 1 |
| Tatsumi, Y | 1 |
| Yoshida, T | 3 |
| Nishizawa, Y | 1 |
| Tatara, T | 1 |
| Tomoda, M | 1 |
| Nagano, I | 1 |
| Yamada, I | 1 |
| Niwa, M | 1 |
| Kanazawa, H | 1 |
| Sato, T | 2 |
| Matsumoto, N | 2 |
| Yoshinaka, H | 1 |
| Ooka, Y | 1 |
| Chiba, T | 1 |
| Ogasawara, S | 1 |
| Arai, K | 4 |
| Suzuki, E | 2 |
| Tawada, A | 1 |
| Yamashita, T | 5 |
| Kanai, F | 1 |
| Yokosuka, O | 2 |
| Fujimura, Y | 1 |
| Nakahara, O | 1 |
| Otao, R | 1 |
| Baba, H | 6 |
| Hasegawa, Y | 3 |
| Iwata, H | 1 |
| Hatanaka, M | 1 |
| Shimao, K | 1 |
| Yano, M | 2 |
| Sasaki, K | 4 |
| Goto, T | 2 |
| Zhang, ZD | 1 |
| Kong, Y | 1 |
| Yang, W | 1 |
| Zhang, B | 1 |
| Zhang, YL | 1 |
| Ma, EM | 1 |
| Liu, HX | 1 |
| Chen, XB | 1 |
| Hua, YW | 1 |
| Miyamoto, M | 5 |
| Misawa, S | 1 |
| Iida, T | 1 |
| Nakabayashi, Y | 1 |
| Okui, N | 1 |
| Shiba, H | 1 |
| Otsuka, M | 1 |
| Terazawa, T | 1 |
| Kondo, S | 2 |
| Hosoi, H | 1 |
| Morizane, C | 4 |
| Shimizu, S | 4 |
| Mitsunaga, S | 2 |
| Ueno, H | 6 |
| Shiina, S | 1 |
| Nakachi, K | 3 |
| Kojima, Y | 1 |
| Sakamoto, Y | 2 |
| Asaoka, Y | 1 |
| Tateishi, R | 1 |
| Arioka, H | 1 |
| Sunami, T | 1 |
| Tauchi, J | 1 |
| Sakashita, K | 1 |
| Yukimoto, K | 1 |
| Sawada, R | 1 |
| Koike, M | 2 |
| Mino, K | 1 |
| Shoji, H | 1 |
| Konishi, Y | 1 |
| Katayama, T | 1 |
| Kuwahara, H | 1 |
| Kon, H | 1 |
| Tamura, M | 1 |
| Iwasaki, S | 1 |
| Suzuki, A | 2 |
| Akasaka, Y | 1 |
| Mitan, M | 1 |
| Tsuda, H | 1 |
| Nishiwaki, K | 2 |
| Kagawa, I | 2 |
| Matsumoto, Y | 3 |
| Kishi, S | 1 |
| Yokohira, M | 1 |
| Imaida, K | 1 |
| Saoo, K | 1 |
| Cheng, AL | 1 |
| Li, J | 1 |
| Vaid, AK | 1 |
| Ma, BB | 1 |
| Teh, C | 1 |
| Ahn, JB | 2 |
| Bello, M | 1 |
| Charoentum, C | 1 |
| Chen, LT | 1 |
| de Lima Lopes, G | 1 |
| Ho, GF | 1 |
| Kong, HL | 1 |
| Lam, KO | 1 |
| Liu, TS | 1 |
| Park, YS | 2 |
| Sriuranpong, V | 1 |
| Sudoyo, AW | 1 |
| Wang, JY | 1 |
| Zhang, J | 2 |
| Zhang, SZ | 1 |
| Ciardiello, F | 1 |
| Köhne, CH | 1 |
| Shaw, M | 1 |
| Kim, TW | 3 |
| Tsuchiya, Y | 2 |
| Aizawa, M | 1 |
| Nomura, T | 1 |
| Nashimoto, A | 2 |
| Fukuda, N | 1 |
| Niki, M | 2 |
| Sano, M | 1 |
| Ogura, R | 1 |
| Wada, J | 1 |
| Okumura, T | 1 |
| Nakamura, J | 1 |
| Kai, K | 1 |
| Ide, Y | 1 |
| Nakamura, H | 3 |
| Koga, H | 1 |
| Ide, T | 1 |
| Miyoshi, A | 1 |
| Kitahara, K | 1 |
| Noshiro, H | 1 |
| Izumo, W | 1 |
| Furukawa, K | 2 |
| Katsuragawa, H | 1 |
| Komatsu, A | 1 |
| Shigematsu, K | 1 |
| Shan, F | 1 |
| Zhang, LH | 1 |
| Bu, ZD | 1 |
| Wu, AW | 1 |
| Wu, XJ | 1 |
| Zong, XL | 1 |
| Li, SX | 1 |
| Ji, X | 1 |
| Ji, JF | 1 |
| Konishi, K | 4 |
| Hiraoka, K | 1 |
| Nakagawa, T | 1 |
| Kim, C | 1 |
| Endo, S | 2 |
| Yamada, T | 3 |
| Nishijima, J | 1 |
| Imai, H | 1 |
| Sawada, K | 1 |
| Sato, A | 1 |
| Nishi, K | 1 |
| Takahashi, T | 6 |
| Ohori, H | 1 |
| Kaneko, J | 2 |
| Isogai, J | 2 |
| Hasegawa, K | 4 |
| Aoyagi, H | 2 |
| Maejima, S | 2 |
| Hata, T | 2 |
| Wada, H | 12 |
| Tomokuni, A | 3 |
| Hama, N | 3 |
| Kawamoto, K | 3 |
| Asaoka, T | 1 |
| Marubashi, S | 13 |
| Eguchi, H | 8 |
| Umeshita, K | 11 |
| Takiguchi, S | 2 |
| Mori, M | 8 |
| Doki, Y | 8 |
| Nagano, H | 14 |
| Fujisaki, S | 1 |
| Takashina, M | 1 |
| Tomita, R | 1 |
| Sakurai, K | 4 |
| Takayama, T | 5 |
| Maeda, T | 1 |
| Tsuchiya, M | 1 |
| Ishii, J | 1 |
| Koda, T | 1 |
| Kubota, Y | 1 |
| Katagiri, T | 1 |
| Tamura, A | 1 |
| Otsuka, Y | 1 |
| Shibuya, K | 1 |
| Nakayama, A | 1 |
| Shoji, M | 1 |
| Nakanuma, S | 1 |
| Makino, I | 2 |
| Hayashi, H | 2 |
| Nakagawara, H | 1 |
| Takamura, H | 2 |
| Kumazu, Y | 1 |
| Aoyama, T | 1 |
| Kitani, Y | 1 |
| Yukawa, N | 1 |
| Yoshikawa, T | 1 |
| Rino, Y | 2 |
| Ozawa, Y | 1 |
| Masuda, M | 1 |
| Nagai, Y | 2 |
| Kato, T | 6 |
| Harano, M | 1 |
| Satoh, D | 1 |
| Choda, Y | 1 |
| Tokumoto, N | 1 |
| Kanazawa, T | 1 |
| Matsukawa, H | 1 |
| Ojima, Y | 1 |
| Idani, H | 1 |
| Shiozaki, S | 1 |
| Okajima, M | 1 |
| Ninomiya, M | 1 |
| Ohno, S | 1 |
| Otsuru, T | 1 |
| Iijima, S | 3 |
| Tsujimura, N | 1 |
| Nakao, E | 1 |
| Matsumoto, T | 6 |
| Takachi, K | 2 |
| Nishioka, K | 2 |
| Takemoto, H | 2 |
| Oshima, S | 1 |
| Uemura, Y | 2 |
| Kobayashi, K | 3 |
| Higuchi, I | 1 |
| Akiyama, Y | 1 |
| Yamamoto, M | 6 |
| Tanigawa, T | 2 |
| Tojima, Y | 2 |
| Yatsuya, H | 1 |
| Ohara, T | 1 |
| Fujino, Y | 1 |
| Yamashita, H | 2 |
| Oyama, M | 1 |
| Katsura, M | 1 |
| Sugiyama, H | 1 |
| Ueda, Y | 1 |
| Hasegawa, H | 2 |
| Yasuda, T | 2 |
| Kakinoki, K | 1 |
| Oshikiri, T | 1 |
| Sendo, H | 1 |
| Sugimoto, T | 1 |
| Tominaga, M | 1 |
| Lv, Y | 1 |
| Liang, R | 1 |
| Hu, X | 1 |
| Liu, Z | 1 |
| Liao, X | 1 |
| Lin, Y | 1 |
| Yuan, C | 1 |
| Liao, S | 1 |
| Li, Q | 1 |
| Okamoto, K | 1 |
| Nakamura, K | 4 |
| Emi, Y | 2 |
| Miyamoto, Y | 2 |
| Higashi, H | 1 |
| Ogata, Y | 2 |
| Ikebe, M | 2 |
| Tokunaga, S | 1 |
| Beppu, T | 2 |
| Uchida, S | 2 |
| Takatsuki, M | 1 |
| Sakoda, M | 1 |
| Akagi, Y | 1 |
| Natsugoe, S | 4 |
| Seki, H | 3 |
| Ohi, H | 1 |
| Ozaki, T | 1 |
| Yabusaki, H | 2 |
| Bando, H | 1 |
| Yamada, Y | 2 |
| Tanabe, S | 2 |
| Gotoh, M | 2 |
| Nishina, T | 2 |
| Amagai, K | 1 |
| Niwa, Y | 1 |
| Tsuda, M | 1 |
| Fujii, H | 1 |
| Hironaka, S | 3 |
| Shimada, K | 1 |
| Miwa, H | 3 |
| Hamada, C | 1 |
| Hyodo, I | 1 |
| Cao, C | 1 |
| Kuang, M | 1 |
| Xu, W | 1 |
| Zhang, X | 1 |
| Tang, C | 1 |
| Martin, M | 1 |
| Lopez-Tarruella, S | 1 |
| Takashima, T | 1 |
| Mukai, H | 1 |
| Hara, F | 2 |
| Matsubara, N | 1 |
| Takano, T | 1 |
| Park, Y | 1 |
| Toyama, T | 1 |
| Hozumi, Y | 1 |
| Tsurutani, J | 1 |
| Imoto, S | 1 |
| Watanabe, T | 4 |
| Sagara, Y | 4 |
| Nishimura, R | 1 |
| Shimozuma, K | 1 |
| Ohashi, Y | 1 |
| Aoki, S | 1 |
| Mizuma, M | 1 |
| Oyauchi, M | 1 |
| Yoshida, H | 2 |
| Okada, R | 1 |
| Abe, T | 1 |
| Nakagawa, K | 2 |
| Morikawa, T | 1 |
| Motoi, F | 1 |
| Naitoh, T | 1 |
| Unno, M | 1 |
| Yasumoto, T | 1 |
| Yakushiji, H | 2 |
| Ohira, R | 1 |
| Ohara, N | 1 |
| Nakata, S | 1 |
| Hatano, H | 2 |
| Noda, T | 3 |
| Oh, RJ | 1 |
| Hirabuki, N | 1 |
| Saso, K | 1 |
| Murata, M | 1 |
| Asai, K | 1 |
| Yamada, M | 1 |
| Yagi, T | 1 |
| Katsuyama, S | 1 |
| Sawami, H | 1 |
| Takahashi, H | 2 |
| Takayama, O | 1 |
| Tanaka, N | 4 |
| Baba, M | 2 |
| Hiratsuka, M | 2 |
| Hosoda, Y | 1 |
| Yamasaki, M | 1 |
| Yasui, M | 1 |
| Shimada, T | 1 |
| Sakata, J | 1 |
| Yamamoto, J | 1 |
| Usui, K | 1 |
| Naito, T | 1 |
| Tani, T | 1 |
| Hasegawa, J | 2 |
| Shimakage, N | 1 |
| Wakai, T | 2 |
| Ozato, Y | 1 |
| Kawabata, R | 2 |
| Yoshikawa, M | 1 |
| Kameda, C | 1 |
| Koga, C | 1 |
| Murakami, M | 3 |
| Noura, S | 1 |
| Ikenaga, M | 1 |
| Shimizu, J | 2 |
| Nakada, S | 1 |
| Kawamoto, J | 1 |
| Yoichi, T | 1 |
| Shinoda, K | 1 |
| Ishigami, E | 1 |
| Teranaka, R | 1 |
| Miyazaki, M | 2 |
| Okada, K | 4 |
| Oka, Y | 2 |
| Miyake, Y | 1 |
| Nakane, S | 1 |
| Ueshima, S | 1 |
| Higaki, N | 2 |
| Hayashida, H | 2 |
| Nezu, R | 1 |
| Nakazawa, K | 2 |
| Tanaka, R | 1 |
| Kametani, N | 1 |
| Hirakawa, T | 2 |
| Kato, Y | 3 |
| Komoto, M | 1 |
| Yamagata, S | 2 |
| Kanehara, I | 2 |
| Ako, E | 2 |
| Yamada, N | 3 |
| Nishimura, S | 2 |
| Taenaka, N | 2 |
| Okamoto, T | 1 |
| Tanaka, K | 3 |
| Yonemitsu, K | 1 |
| Munechika, T | 1 |
| Nomi, M | 1 |
| Maeno, H | 1 |
| Nagao, S | 4 |
| Kawamoto, S | 1 |
| Sasaguri, T | 1 |
| Sueishi, K | 1 |
| Oda, K | 1 |
| Kubosawa, H | 1 |
| Kataoka, M | 1 |
| Arai, S | 1 |
| Oeda, Y | 1 |
| Takagi, T | 3 |
| Suda, H | 1 |
| Omori, K | 1 |
| Suematsu, Y | 1 |
| Ishibashi, Y | 1 |
| Morita, A | 1 |
| Wakabayashi, K | 1 |
| Ito, Y | 2 |
| Eto, R | 1 |
| Nakatsu, H | 1 |
| Ozasa, H | 1 |
| Shimizu, R | 1 |
| Nonoshita, T | 1 |
| Otsuka, S | 1 |
| Inagaki, M | 1 |
| Iwagaki, H | 1 |
| Yamauchi, K | 1 |
| Kokuryo, T | 1 |
| Yokoyama, Y | 1 |
| Yamaguchi, J | 1 |
| Oba, M | 1 |
| Saiura, A | 1 |
| Arita, J | 1 |
| Shinozaki, E | 1 |
| Mizunuma, N | 1 |
| Matsuyama, Y | 1 |
| Kokudo, N | 1 |
| Kuga, Y | 2 |
| Moriya, T | 2 |
| Nishida, T | 2 |
| Tomioku, M | 1 |
| Yazawa, N | 1 |
| Furukawa, D | 1 |
| Izumi, H | 1 |
| Mashiko, T | 1 |
| Ozawa, S | 1 |
| Sadahiro, S | 1 |
| Yasuda, S | 4 |
| Hirabayashi, K | 1 |
| Nakagohri, T | 1 |
| Hara, R | 1 |
| Fujii, T | 2 |
| Ikeda, A | 1 |
| Hashiyata, H | 1 |
| Nakamoto, K | 2 |
| Takeshige, M | 1 |
| Kiyota, S | 1 |
| Matsuda, Y | 2 |
| Hanada, S | 1 |
| Kinoshita, M | 1 |
| Nishizawa, S | 2 |
| Kanazawa, G | 1 |
| Egashira, S | 1 |
| Kajihara, I | 1 |
| Kanemaru, H | 1 |
| Uemura-Kiyohara, M | 1 |
| Yamada-Kanazawa, S | 1 |
| Nakahara, S | 1 |
| Nagamoto, E | 1 |
| Fukushima, S | 1 |
| Jinnin, M | 1 |
| Inoue, Y | 1 |
| Ihn, H | 1 |
| Hiraki, S | 1 |
| Kanesada, K | 1 |
| Harada, T | 2 |
| Tada, K | 1 |
| Hashiguchi, M | 2 |
| Tamai, T | 1 |
| Nasu, Y | 1 |
| Sasaki, F | 1 |
| Higashi, M | 1 |
| Hijikuro, K | 1 |
| Futawatari, H | 1 |
| Shigeta, K | 1 |
| Hasegawa, S | 1 |
| Ido, A | 1 |
| Aoki, Y | 2 |
| Kojima, S | 1 |
| Kataoka, T | 3 |
| Kayukawa, S | 2 |
| Mori, F | 2 |
| Masaki, A | 2 |
| Yamada, K | 2 |
| Kawai, M | 2 |
| Kabeya, M | 1 |
| Hibi, S | 1 |
| Furuta, R | 2 |
| Ina, K | 4 |
| Fujimoto, C | 1 |
| Maruyama, Y | 1 |
| Niina, Y | 1 |
| Fujimori, N | 1 |
| Sumii, T | 2 |
| Funakoshi, A | 2 |
| Matsutani, T | 2 |
| Mizutani, T | 1 |
| Maruyama, H | 4 |
| Yokoyama, T | 2 |
| Yanagi, K | 2 |
| Matsushita, A | 2 |
| Kashiwabara, M | 1 |
| Matsuda, A | 1 |
| Nishi, Y | 1 |
| Arai, H | 1 |
| Sasajima, K | 2 |
| Tajiri, T | 3 |
| Ishigami, S | 3 |
| Nakajo, A | 2 |
| Uenosono, Y | 2 |
| Arigami, T | 2 |
| Setoyama, T | 2 |
| Uchikado, Y | 2 |
| Matsumoto, M | 4 |
| Aikou, T | 3 |
| Tokunaga, M | 3 |
| Tanabe, Y | 1 |
| Nasu, T | 3 |
| Abe, Y | 1 |
| Mitsuyama, S | 2 |
| Toyoshima, S | 1 |
| Takeuchi, Y | 2 |
| Fukuoka, T | 1 |
| Miwa, T | 1 |
| Nishio, T | 1 |
| Ando, T | 3 |
| Lee, JL | 2 |
| Kang, YK | 2 |
| Kang, HJ | 1 |
| Lee, KH | 1 |
| Zang, DY | 1 |
| Ryoo, BY | 2 |
| Kim, JG | 1 |
| Park, SR | 1 |
| Kang, WK | 2 |
| Shin, DB | 1 |
| Ryu, MH | 2 |
| Chang, HM | 2 |
| Baek, JH | 1 |
| Min, YJ | 1 |
| Udagawa, I | 1 |
| Yasutomi, J | 1 |
| Kusashio, K | 1 |
| Kasagawa, T | 1 |
| Tonooka, T | 1 |
| Tashima, Y | 1 |
| Irabu, S | 1 |
| Nobumoto, D | 1 |
| Suzuki, M | 3 |
| Fukao, K | 1 |
| Morinaga, S | 2 |
| Yamamoto, Y | 2 |
| Sugano, N | 1 |
| Shiozawa, M | 1 |
| Akaike, M | 1 |
| Sugimasa, Y | 1 |
| Uka, K | 1 |
| Aikata, H | 2 |
| Mori, N | 2 |
| Takaki, S | 2 |
| Kawakami, Y | 2 |
| Azakami, T | 1 |
| Jeong, SC | 1 |
| Takahashi, S | 4 |
| Chayama, K | 2 |
| Mazaki, T | 1 |
| Mado, K | 1 |
| Manmoto, J | 1 |
| Okame, H | 1 |
| Ishii, Y | 1 |
| Masuda, H | 1 |
| Shiba, E | 1 |
| Yamamoto, H | 2 |
| Takahara, S | 1 |
| Tokushima, H | 1 |
| Osaki, Y | 1 |
| Tokudome, N | 1 |
| Sugihara, T | 2 |
| Iwase, T | 1 |
| Hatake, K | 1 |
| Tawada, K | 1 |
| Ishihara, T | 1 |
| Kobayashi, A | 1 |
| Tsuyuguchi, T | 1 |
| Matsuyama, M | 2 |
| Tokunaga, N | 2 |
| Itaba, S | 1 |
| Yoshinaga, S | 1 |
| Murao, H | 1 |
| Akiho, H | 1 |
| Nagai, E | 1 |
| Goto, A | 1 |
| Segawa, Y | 1 |
| Takayanagi, R | 1 |
| Ueshima, K | 3 |
| Nagai, T | 1 |
| Tatsumi, C | 1 |
| Ueda, T | 1 |
| Hatanaka, K | 2 |
| Kitai, S | 1 |
| Ishikawa, E | 1 |
| Inoue, T | 2 |
| Hagiwara, S | 3 |
| Minami, Y | 1 |
| Chung, H | 2 |
| Kishimoto, T | 2 |
| Furukawa, H | 4 |
| Miyazaki, Y | 2 |
| Yamamoto, T | 4 |
| Fukunaga, M | 3 |
| Ohzato, H | 2 |
| Tatsuta, M | 2 |
| Tokairin, Y | 1 |
| Iida, M | 1 |
| Yamazaki, S | 1 |
| Nakata, K | 3 |
| Suzuki, R | 2 |
| Uji, K | 2 |
| Yoshida, A | 1 |
| Yoshimura, M | 1 |
| Nakahira, S | 3 |
| Miki, H | 3 |
| Sugimoto, K | 3 |
| Tamura, S | 4 |
| Iizuka, T | 1 |
| Hirano, N | 1 |
| Kikuchi, D | 1 |
| Hoteya, S | 1 |
| Yahagi, N | 1 |
| Sekino, Y | 1 |
| Okada, M | 2 |
| Hamada, J | 1 |
| Tagami, S | 1 |
| Sakon, M | 4 |
| Okita, K | 2 |
| Takata, M | 1 |
| Hayashi, K | 2 |
| Munakata, Y | 1 |
| Kitajima, Y | 1 |
| Yakabe, T | 1 |
| Ohtsuka, T | 1 |
| Tanaka, M | 4 |
| Sato, S | 2 |
| Nakafusa, Y | 1 |
| Miyazaki, K | 1 |
| Fujimura, T | 2 |
| Yagi, Y | 1 |
| Niwa, T | 1 |
| Amano, A | 2 |
| Masaki, T | 1 |
| Miyakawa, K | 2 |
| Kimura, H | 2 |
| Mukawa, A | 1 |
| Naito, M | 1 |
| Shinohara, T | 1 |
| Ishii, F | 1 |
| Shibata, R | 1 |
| Yamaguchi, R | 1 |
| Maki, K | 1 |
| Hoshino, S | 1 |
| Tanaka, S | 3 |
| Shibata, N | 1 |
| Eto, TA | 1 |
| Asada, T | 1 |
| Takaya, T | 1 |
| Shimayama, T | 1 |
| Imada, S | 1 |
| Futami, S | 1 |
| Chijiiwa, K | 1 |
| Tanisaka, Y | 1 |
| Seike, H | 1 |
| Tanaka, Y | 2 |
| Tsubouchi, E | 1 |
| Miyauchi, S | 1 |
| Iwakawa, K | 1 |
| Ichikawa, M | 1 |
| Koizumi, W | 3 |
| Takiuchi, H | 3 |
| Boku, N | 5 |
| Fuse, N | 1 |
| Muro, K | 2 |
| Komatsu, Y | 3 |
| Kochi, M | 2 |
| Kanamori, N | 2 |
| Kaiga, T | 2 |
| Funada, T | 1 |
| Tomita, K | 1 |
| Nishijima, W | 1 |
| Tsukuda, M | 1 |
| Ishitoya, J | 1 |
| Yamane, H | 1 |
| Homma, A | 1 |
| Tomita, T | 1 |
| Itoh, Y | 1 |
| Nakagawa, S | 2 |
| Takii, Y | 1 |
| Otsuo, T | 1 |
| Kubota, H | 1 |
| Matsumoto, H | 4 |
| Saito, A | 1 |
| Murakami, H | 1 |
| Higashida, M | 1 |
| Hirabayashi, Y | 1 |
| Okumura, H | 2 |
| Uragami, A | 1 |
| Yamashita, K | 1 |
| Hirai, T | 1 |
| Yoden, E | 1 |
| Hiratsuka, J | 1 |
| Igarashi, Y | 1 |
| Aoki, T | 4 |
| Yamanaka, C | 2 |
| Komori, T | 1 |
| Hashimoto, K | 3 |
| Kashiwazaki, M | 1 |
| Okubo, K | 1 |
| Akitake, H | 1 |
| Ohtsuka, M | 1 |
| Maekawa, T | 1 |
| Taniguchi, M | 3 |
| Tsujie, M | 2 |
| Konishi, M | 1 |
| Fujimoto, T | 1 |
| Takeda, Y | 8 |
| Tanemura, M | 6 |
| Wakasa, K | 3 |
| Kitagawa, T | 2 |
| Monden, M | 8 |
| Nakamori, S | 3 |
| Morishima, K | 1 |
| Hyodo, M | 1 |
| Nihei, Y | 1 |
| Sata, N | 1 |
| Yasuda, Y | 1 |
| Kanou, M | 1 |
| Kurisu, Y | 1 |
| Akagi, S | 1 |
| Tanaka, T | 5 |
| Toge, K | 1 |
| Nobuhara, Y | 1 |
| Kubo, N | 4 |
| Matuoka, T | 1 |
| Yo, T | 1 |
| Yamamoto, K | 2 |
| Matsuyama, S | 2 |
| Sonoda, K | 1 |
| Murakami, S | 3 |
| Higaki, K | 1 |
| Nasu, K | 1 |
| Kikuno, M | 1 |
| Kawaguchi, M | 1 |
| Asada, Y | 1 |
| Terada, T | 2 |
| Takehara, A | 1 |
| Munemoto, Y | 2 |
| Mitsui, T | 2 |
| Iida, Y | 2 |
| Sudo, Y | 1 |
| Miyahira, T | 1 |
| Teruya, N | 1 |
| Matsuura, F | 1 |
| Murayama, S | 1 |
| Aka, H | 1 |
| Teruya, J | 1 |
| Hanashiro, N | 1 |
| Nishihara, M | 1 |
| Okushima, N | 1 |
| Toda, Y | 1 |
| Kiyuna, M | 1 |
| Yokoo, H | 2 |
| Kamiyama, T | 2 |
| Nakanishi, K | 2 |
| Tahara, M | 2 |
| Fukumori, D | 1 |
| Kamachi, H | 2 |
| Matsushita, M | 2 |
| Todo, S | 2 |
| Oka, T | 1 |
| Tokumo, M | 1 |
| Yamakawa, T | 1 |
| Onoda, Y | 1 |
| Suzuka, I | 1 |
| Shiota, K | 1 |
| Hashimoto, M | 2 |
| Moriyuki, T | 1 |
| Kuranishi, F | 1 |
| Niitsu, H | 1 |
| Fujikuni, N | 1 |
| Iwako, H | 1 |
| Kuroda, Y | 1 |
| Sakaguchi, H | 1 |
| Aizawa, K | 1 |
| Muramatsu, S | 1 |
| Kumaki, T | 1 |
| Kasuga, Y | 1 |
| Ogura, M | 1 |
| Furuya, T | 1 |
| Nomura, Y | 1 |
| Nagai, M | 1 |
| Hirao, H | 1 |
| Taku, K | 2 |
| Yokota, T | 1 |
| Shitara, K | 5 |
| Kojima, T | 1 |
| Ueda, S | 1 |
| Machida, N | 2 |
| Kamigaki, S | 1 |
| Arai, T | 1 |
| Ohsato, H | 1 |
| Sohta, Y | 1 |
| Kaze, C | 1 |
| Matsuda, S | 2 |
| Yabuno, T | 1 |
| Mochizuki, Y | 1 |
| Kito, F | 1 |
| Kunisaki, C | 2 |
| Sato, I | 1 |
| Kinoshita, E | 1 |
| Minato, H | 1 |
| Ohno, K | 1 |
| Nakaya, N | 1 |
| Shimasaki, T | 1 |
| Nakajima, H | 2 |
| Motoo, Y | 1 |
| Akazawa, N | 1 |
| Taguchi, K | 1 |
| Imai, A | 1 |
| Kikuchi, H | 1 |
| Minato, M | 1 |
| Iwaki, H | 1 |
| Yamaki, K | 1 |
| Morisaki, T | 2 |
| Hasegawa, T | 1 |
| Tachimori, A | 2 |
| Enomoto, J | 1 |
| Yamaguchi, M | 1 |
| Takita, M | 1 |
| Haji, S | 1 |
| Arao, T | 1 |
| Nishio, K | 1 |
| Park, AM | 1 |
| Munakata, H | 1 |
| Shikano, T | 1 |
| Hattori, K | 1 |
| Kinoshita, T | 1 |
| Hachisuka, T | 1 |
| Mori, T | 2 |
| Shinohara, M | 1 |
| Miyauchi, M | 1 |
| Fukui, H | 2 |
| Kou, C | 2 |
| Tomizawa, K | 1 |
| Matsuda, M | 1 |
| Udagawa, H | 1 |
| Sawada, T | 4 |
| Watanabe, G | 1 |
| Sato, H | 1 |
| Ogasawara, T | 1 |
| Tsujii, S | 1 |
| Nagahori, J | 1 |
| Matsuoka, A | 1 |
| Ishii, H | 2 |
| Amaya, S | 1 |
| Koizumi, H | 1 |
| Yamamoto, D | 1 |
| Kanematsu, S | 1 |
| Ah, K | 1 |
| Kim, SJ | 1 |
| Han, SW | 1 |
| Oh, DY | 1 |
| Yi, NJ | 1 |
| Kim, YJ | 1 |
| Im, SA | 1 |
| Yoon, JH | 1 |
| Kang, GH | 1 |
| Suh, KS | 1 |
| Bang, YJ | 1 |
| Jang, JJ | 1 |
| Kim, TY | 1 |
| Shimizu, H | 1 |
| Itokawa, Y | 1 |
| Shioaki, Y | 1 |
| Sonoda, H | 1 |
| Ikeda, J | 1 |
| Koide, K | 1 |
| Taniguchi, F | 1 |
| Ueshima, Y | 1 |
| Takashina, K | 1 |
| Otsuji, E | 1 |
| Iwauchi, T | 1 |
| Amano, R | 4 |
| Ohira, G | 1 |
| Doi, Y | 1 |
| Ohira, M | 4 |
| Hirakawa, K | 4 |
| Nakase, Y | 1 |
| Fukumoto, K | 1 |
| Miyagaki, T | 1 |
| Ishida, E | 1 |
| Kobayashi, Y | 1 |
| Soga, K | 2 |
| Kanemitsu, D | 1 |
| Kassai, K | 1 |
| Takenaka, S | 1 |
| Yanagida, K | 1 |
| Itani, K | 1 |
| Fukumoto, I | 1 |
| Minagawa, R | 1 |
| Hamatsu, T | 1 |
| Honboh, T | 1 |
| Ushijima, C | 1 |
| Kitamura, M | 4 |
| Ohhinata, R | 1 |
| Iwasaki, Y | 4 |
| Iwanaga, T | 2 |
| Takahashi, K | 4 |
| Nakano, D | 1 |
| Maeda, Y | 1 |
| Sasaki, E | 2 |
| Katsuta, E | 1 |
| Someno, Y | 1 |
| Saguchi, M | 1 |
| Takahata, T | 2 |
| Yamada, D | 1 |
| Sogabe, S | 1 |
| Yuki, S | 1 |
| Kusumi, T | 1 |
| Miyagishima, T | 1 |
| Hosokawa, A | 2 |
| Iwanaga, I | 1 |
| Sakata, Y | 6 |
| Asaka, M | 1 |
| Hatata, T | 1 |
| Takaya, S | 1 |
| Taniguchi, K | 1 |
| Naka, T | 1 |
| Kondo, A | 1 |
| Ikeguchi, M | 1 |
| Nishimizu, T | 1 |
| Minemura, M | 1 |
| Kajiura, S | 1 |
| Tokimitsu, Y | 1 |
| Itaya, Y | 1 |
| Yamawaki, H | 1 |
| Tajiri, K | 1 |
| Nakayama, Y | 1 |
| Takahara, T | 1 |
| Yasumura, S | 1 |
| Fukuoka, J | 1 |
| Ishizawa, S | 1 |
| Sawasaki, T | 1 |
| Yanagisawa, A | 1 |
| Sugiyama, T | 1 |
| Kiyoto, S | 1 |
| Takabatake, D | 1 |
| Takashima, S | 2 |
| Aogi, K | 1 |
| Ohsumi, S | 1 |
| Kameda, R | 1 |
| Kanazawa, A | 1 |
| Schultheis, B | 1 |
| Strumberg, D | 1 |
| Bergmann, L | 1 |
| Graeven, U | 1 |
| Hanauske, AR | 1 |
| Lipp, R | 1 |
| Schuette, J | 1 |
| Scigalla, P | 1 |
| Scheulen, ME | 1 |
| Tamada, S | 1 |
| Baba, S | 1 |
| Yotsumoto, D | 1 |
| Matsukata, A | 1 |
| Andou, M | 1 |
| Rai, Y | 1 |
| Matsumoto, K | 2 |
| Hirano, T | 1 |
| Sada, M | 1 |
| Mizukami, T | 1 |
| Kakisaka, T | 1 |
| Iwase, H | 2 |
| Shimada, M | 2 |
| Tsuzuki, T | 1 |
| Sugihara, M | 1 |
| Haruta, J | 2 |
| Shinoda, M | 2 |
| Kumada, T | 1 |
| Lee, SJ | 1 |
| Lee, J | 3 |
| Park, SH | 1 |
| Park, JO | 1 |
| Yim, DS | 1 |
| Lim, HY | 1 |
| Kuga, T | 1 |
| Oka, K | 1 |
| Yamashita, A | 1 |
| Fujii, Y | 1 |
| Hanashima, M | 1 |
| Hamano, K | 1 |
| Yoshimura, G | 1 |
| Ito, D | 1 |
| Furumoto, K | 1 |
| Kogire, M | 1 |
| Aono, K | 1 |
| Yasui, A | 1 |
| Takeno, A | 1 |
| Kanemura, T | 1 |
| Yanai, A | 1 |
| Yoshioka, Y | 2 |
| Teramoto, A | 1 |
| Egawa, C | 1 |
| Takatsuka, Y | 2 |
| Tsushima, T | 2 |
| Fukutomi, A | 2 |
| Todaka, A | 1 |
| Taniguchi, H | 2 |
| Onozawa, Y | 1 |
| Narita, T | 1 |
| Seshimo, A | 1 |
| Itabashi, M | 1 |
| Aratake, K | 1 |
| Ogawa, S | 1 |
| Hirosawa, T | 1 |
| Amano, K | 1 |
| Kameoka, S | 1 |
| Nitori, N | 1 |
| Kato, A | 1 |
| Deguchi, T | 1 |
| Okada, A | 1 |
| Kojima, M | 1 |
| Kuroda, J | 1 |
| Kadomura, T | 1 |
| Kubota, K | 1 |
| Origuchi, N | 1 |
| Fujisaki, M | 2 |
| Takeji, S | 1 |
| Asagi, A | 1 |
| Kajiwara, T | 1 |
| Hori, S | 1 |
| Ikeda, Y | 2 |
| Nadano, S | 1 |
| Iguchi, H | 1 |
| Koo, DH | 1 |
| Lee, SS | 1 |
| Moon, JH | 1 |
| Okazaki, S | 1 |
| Ohtsukasa, S | 1 |
| Nakajima, Y | 1 |
| Kamiya, A | 1 |
| Takamatsu, S | 1 |
| Kawachi, Y | 1 |
| Ito, G | 1 |
| Muguruma, K | 3 |
| Nagahara, H | 3 |
| Noda, E | 3 |
| Yashiro, M | 1 |
| Maeda, K | 4 |
| Nakata, B | 1 |
| Sanada, T | 1 |
| Wakabayashi, M | 1 |
| Kuwabara, H | 1 |
| Nakajima, K | 1 |
| Goseki, N | 1 |
| Miyake, M | 1 |
| Kawanishi, K | 1 |
| Fujita, J | 2 |
| Kitada, M | 1 |
| Shimano, T | 1 |
| Katsura, Y | 1 |
| Ishizawa, Y | 1 |
| Aizawa, S | 1 |
| Okudera, D | 1 |
| Yokoyama, M | 1 |
| Aizawa, H | 2 |
| Satoh, Y | 1 |
| Kasai, M | 2 |
| Munakata, M | 5 |
| Hakamada, K | 1 |
| Wada, S | 1 |
| Okamura, R | 1 |
| Yoh, T | 1 |
| Nobutou, Y | 1 |
| Higashiyama, M | 1 |
| Nakayama, H | 1 |
| Miyagawa, K | 1 |
| Hiura, M | 1 |
| Taguchi, M | 1 |
| Kihara, Y | 1 |
| Abe, S | 2 |
| Shimajiri, S | 2 |
| Harada, M | 1 |
| Mori, Y | 2 |
| Ohtani, H | 1 |
| Tamamori, Y | 1 |
| Azuma, T | 1 |
| Ishibashi, N | 1 |
| Murakami, N | 1 |
| Kibe, S | 1 |
| Yahara, T | 1 |
| Shirouzu, K | 3 |
| Masuishi, T | 1 |
| Sakai, Y | 1 |
| Soma, T | 1 |
| Nagayama, K | 1 |
| Kusano, F | 1 |
| Tazawa, J | 1 |
| El-Omar, EM | 1 |
| Takashi, H | 1 |
| Suzuki, T | 5 |
| Murayama, M | 1 |
| Morise, K | 1 |
| Komatsubara, T | 1 |
| Inamoto, S | 1 |
| Teramura, Y | 1 |
| Hashida, S | 1 |
| Akamatsu, S | 1 |
| Hamai, Y | 2 |
| Hihara, J | 2 |
| Emi, M | 1 |
| Kushitani, K | 1 |
| Tanabe, K | 2 |
| Kagawa, K | 2 |
| Honda, Y | 1 |
| Nakahara, T | 1 |
| Naeshiro, N | 1 |
| Miyaki, D | 1 |
| Nagaoki, Y | 1 |
| Hiramatsu, A | 1 |
| Waki, K | 1 |
| Hyogo, H | 1 |
| Arihiro, K | 1 |
| Sanetou, H | 1 |
| Sakaguchi, K | 1 |
| Takahashi, Y | 2 |
| Tanizawa, Y | 2 |
| Bando, E | 2 |
| Kawamura, T | 2 |
| Kanemoto, H | 2 |
| Uesaka, K | 2 |
| Aramaki, T | 2 |
| Terashima, M | 3 |
| Terashima, T | 1 |
| Sunagozaka, H | 2 |
| Shimakami, T | 1 |
| Mizukoshi, E | 1 |
| Sakai, A | 1 |
| Honda, M | 1 |
| Fujioka, M | 1 |
| Lee, T | 1 |
| Ishikawa, T | 1 |
| Toyama, H | 1 |
| Matsumoto, I | 1 |
| Shinzeki, M | 1 |
| Shirakawa, S | 1 |
| Ajiki, T | 1 |
| Ueno, K | 1 |
| Sawa, H | 1 |
| Otsubo, I | 1 |
| Kido, M | 1 |
| Fukumoto, T | 1 |
| Ku, Y | 1 |
| Akita, H | 1 |
| Ohashi, I | 1 |
| Arai, I | 1 |
| Tamura, C | 1 |
| Inoue, S | 2 |
| Fujii, C | 1 |
| Izeki, C | 1 |
| Itsui, Y | 1 |
| Watanabe, M | 3 |
| Yoshida, R | 1 |
| Akashi, T | 1 |
| Yauchi, T | 1 |
| Takeyoshi, I | 1 |
| Hirai, K | 1 |
| Miyamae, Y | 1 |
| Takahashi, N | 2 |
| Tsukagoshi, H | 1 |
| Ogawa, H | 1 |
| Toya, H | 1 |
| Totsuka, O | 1 |
| Yoshinari, D | 1 |
| Sunose, Y | 1 |
| Makuuchi, R | 1 |
| Miki, Y | 1 |
| Yamakawa, Y | 1 |
| Sugisawa, N | 1 |
| Wang, X | 1 |
| Wang, ML | 1 |
| Zhou, LY | 1 |
| Lu, XY | 1 |
| Yang, JF | 1 |
| Yu, HG | 1 |
| Kubo, S | 2 |
| Misawa, T | 2 |
| Ihara, Y | 2 |
| Chinen, T | 1 |
| Harada, N | 2 |
| Nawada, H | 1 |
| Saikawa, Y | 2 |
| Kanai, T | 2 |
| Kawano, Y | 1 |
| Otani, Y | 1 |
| Kubota, T | 2 |
| Tasaka, K | 1 |
| Tomofuji, Y | 1 |
| Chinzei, T | 1 |
| Watanabe, S | 1 |
| Takeuchi, T | 1 |
| Takabayashi, H | 1 |
| Hirayama, Y | 1 |
| Tanino, M | 1 |
| Mizuno, C | 1 |
| Shiomi, T | 1 |
| Shima, T | 1 |
| Nakajo, S | 1 |
| Hara, A | 2 |
| Iwabuchi, M | 1 |
| Imai, G | 1 |
| Yokoyama, H | 1 |
| Mochida, A | 1 |
| Shiina, M | 1 |
| Ishibashi, J | 1 |
| Chida, N | 1 |
| Tadokoro, K | 1 |
| Fujito, T | 1 |
| Goda, F | 2 |
| Matsuyama, J | 1 |
| Hojo, S | 1 |
| Yano, Y | 1 |
| Endo, W | 1 |
| Maeura, Y | 1 |
| Takahashi, I | 1 |
| Sakurai, M | 1 |
| Yonemura, Y | 1 |
| Endo, K | 1 |
| Toh, Y | 1 |
| Kohnoe, S | 1 |
| Okamura, T | 1 |
| Kawai, H | 1 |
| Ohtsu, A | 1 |
| Hamamoto, Y | 1 |
| Muto, M | 1 |
| Sano, Y | 1 |
| Mera, K | 1 |
| Yano, T | 1 |
| Doi, T | 1 |
| Yoshida, S | 1 |
| Cho, H | 1 |
| Kobayashi, O | 1 |
| Sairenji, M | 1 |
| Motohashi, H | 1 |
| Imada, T | 2 |
| Usuki, H | 1 |
| Ishimura, K | 1 |
| Yachida, S | 1 |
| Hagiike, M | 1 |
| Okano, K | 1 |
| Izuishi, K | 1 |
| Karasawa, Y | 1 |
| Maeta, H | 1 |
| Tsujitani, S | 1 |
| Fukuda, K | 1 |
| Kaibara, N | 1 |
| Fujiwara, H | 1 |
| Takagane, A | 2 |
| Abe, K | 1 |
| Irinoda, T | 3 |
| Nakaya, T | 1 |
| Yonezawa, H | 1 |
| Kanzaki, N | 1 |
| Ohtani, S | 1 |
| Nemoto, T | 1 |
| Hoshino, Y | 1 |
| Kogure, M | 1 |
| Takemura, M | 1 |
| Osugi, H | 1 |
| Lee, S | 1 |
| Taguchi, S | 1 |
| Kaneko, M | 2 |
| Fukuhara, K | 1 |
| Fujiwara, Y | 4 |
| Kinoshita, H | 1 |
| Kawabata, H | 1 |
| Takase, I | 1 |
| Murata, A | 1 |
| Meguro, E | 2 |
| Kaizuka, H | 1 |
| Inaba, T | 1 |
| Hayakawa, Y | 2 |
| Okada, S | 1 |
| Yamaguchi, S | 1 |
| Wakabayashi, J | 1 |
| Hirahata, S | 1 |
| Maeda, D | 1 |
| Kamei, S | 1 |
| Tokura, H | 1 |
| Inuzuka, K | 1 |
| Hunabashi, M | 1 |
| Hino, T | 1 |
| Ishida, O | 1 |
| Takemoto, R | 2 |
| Shakado, S | 2 |
| Yamashita, N | 2 |
| Nishi, H | 2 |
| Fukumori, K | 2 |
| Fukuizumi, K | 2 |
| Miyahara, T | 2 |
| Sakai, H | 2 |
| Yasumori, K | 2 |
| Muranaka, T | 2 |
| Takami, Y | 2 |
| Saitsu, H | 2 |
| Sata, M | 1 |
| Nishi, T | 2 |
| Morita, M | 1 |
| Okamoto, Y | 1 |
| Nabeshima, K | 1 |
| Soeda, J | 1 |
| Kondo, Y | 1 |
| Ogoshi, K | 1 |
| Tajima, T | 1 |
| Makuuchi, H | 1 |
| Akaiwa, J | 1 |
| Nakao, K | 2 |
| Koishi, K | 1 |
| Nishizaki, K | 1 |
| Ooiwa, N | 1 |
| Yamamura, T | 1 |
| Maruyama, N | 1 |
| Maruyama, K | 1 |
| Furukawa, J | 1 |
| Tanaka, J | 1 |
| Katsumoto, Y | 1 |
| Nakaguchi, K | 1 |
| Sue, F | 1 |
| Tokumitsu, Y | 1 |
| Nagano, C | 1 |
| Matsuura, T | 1 |
| Seo, M | 1 |
| Mitsugi, K | 1 |
| Tamaki, T | 1 |
| Simada, K | 1 |
| Tubakihara, H | 1 |
| Tujimura, H | 1 |
| Ishiyama, T | 1 |
| Inazawa, K | 1 |
| Shiraishi, K | 1 |
| Kitada, K | 1 |
| Noda, H | 1 |
| Takenaka, H | 1 |
| Morita, N | 1 |
| Iyo, T | 1 |
| Nakarai, K | 1 |
| Kaida, S | 1 |
| Indo, T | 1 |
| Doi, R | 1 |
| Okeya, M | 1 |
| Makari, Y | 2 |
| Suganuma, T | 1 |
| Terauchi, R | 1 |
| Shikina, A | 1 |
| Aozasa, S | 1 |
| Utsunomiya, K | 1 |
| Fujino, K | 1 |
| Ito, H | 1 |
| Tsuda, T | 1 |
| Hase, K | 1 |
| Tokuhara, T | 1 |
| Izumi, N | 1 |
| Iwamoto, S | 1 |
| Satake, K | 1 |
| Katsumata, D | 1 |
| Miyachi, K | 1 |
| Joujima, T | 1 |
| Tsumuraya, M | 1 |
| Onodera, S | 1 |
| Shimoda, W | 1 |
| Yoda, N | 1 |
| Ohkawa, T | 1 |
| Odaka, N | 1 |
| Sunagawa, M | 1 |
| Higuchi, K | 2 |
| Okazaki, H | 1 |
| Suto, R | 1 |
| Hamaguchi, M | 1 |
| Shiba, M | 1 |
| Oshitani, N | 1 |
| Arakawa, T | 1 |
| Aoyagi, K | 1 |
| Koufuji, K | 1 |
| Yano, S | 3 |
| Miyagi, M | 2 |
| Imaizumi, T | 2 |
| Takeda, J | 1 |
| Niinobu, T | 3 |
| Kotobuki, T | 2 |
| Otsuka, A | 1 |
| Kurokawa, E | 1 |
| Ohshima, S | 1 |
| Handa, R | 1 |
| Naoi, Y | 1 |
| Kikkawa, N | 1 |
| Fukunaga, K | 1 |
| Kondo, M | 1 |
| Damdinsuren, B | 3 |
| Yang, Y | 1 |
| Miyamoto, A | 5 |
| Nagahashi, S | 1 |
| Nishiwaki, M | 1 |
| Okuda, K | 1 |
| Kurosawa, Y | 1 |
| Terada, S | 1 |
| Andou, K | 1 |
| Hibi, T | 1 |
| Tsukahara, A | 1 |
| Kaneko, K | 2 |
| Watanabe, A | 1 |
| Ishikawa, H | 1 |
| Ohyama, T | 1 |
| Niimi, Y | 1 |
| Hirohashi, Y | 1 |
| Sumi, K | 1 |
| Ohta, K | 1 |
| Taomoto, J | 1 |
| Toge, T | 1 |
| Ogino, H | 1 |
| Sadamoto, Y | 1 |
| Hatta, W | 1 |
| Kumagai, S | 1 |
| Imamura, J | 1 |
| Oikawa, T | 1 |
| Asano, Y | 1 |
| Kayaba, S | 1 |
| Sawada, M | 1 |
| Kusuda, K | 1 |
| Takehana, K | 1 |
| Endo, Y | 1 |
| Kimizuka, G | 1 |
| Hiraki, M | 1 |
| Hashiguchi, K | 1 |
| Harada, S | 1 |
| Shoji, T | 1 |
| Fukasawa, T | 1 |
| Morita, Y | 1 |
| Kikuchi, Y | 1 |
| Ishiguro, A | 3 |
| Mizuno, Y | 1 |
| Yamanaka, T | 2 |
| Sano, O | 1 |
| Okabe, K | 1 |
| Itani, Y | 1 |
| Nishikawa, Y | 1 |
| Amano, M | 1 |
| Kato, H | 1 |
| Ogata, T | 1 |
| Nishida, J | 1 |
| Seo, K | 1 |
| Hamaya, M | 1 |
| Kouno, T | 1 |
| Tsuchida, A | 2 |
| Terakura, M | 2 |
| Ikawa, S | 1 |
| Kubota, D | 1 |
| Katsuragi, K | 1 |
| Ohba, K | 1 |
| I, S | 1 |
| Itoh, K | 1 |
| Minami, H | 1 |
| Muneoka, K | 1 |
| Shirai, Y | 1 |
| Yokoyama, N | 1 |
| Hatakeyama, K | 2 |
| Hirata, D | 1 |
| Okanobu, H | 1 |
| Imagawa, H | 1 |
| Takemura, Y | 1 |
| Ohya, T | 1 |
| Maruhashi, A | 1 |
| Ito, A | 1 |
| Ito, N | 1 |
| Matsui, W | 1 |
| Inagaki, J | 1 |
| Tsunoda, A | 1 |
| Amagasa, H | 1 |
| Suzuki, N | 1 |
| Kusano, M | 1 |
| Kanazawa, S | 1 |
| Seo, A | 1 |
| Tokura, N | 1 |
| Honda, R | 1 |
| Kase, H | 1 |
| Teramoto, T | 1 |
| Nishihara, K | 1 |
| Kuwakado, S | 1 |
| Goto, M | 2 |
| Kawabe, S | 1 |
| Ohta, S | 1 |
| Kii, T | 1 |
| Nishitani, H | 1 |
| Katsu, K | 1 |
| Hirashima, Y | 1 |
| Kitajima, K | 1 |
| Sugi, S | 1 |
| Murakami, K | 1 |
| Fujioka, T | 1 |
| Noguchi, T | 1 |
| Kataoka, Y | 2 |
| Nio, Y | 1 |
| Itakura, M | 1 |
| Itagaki, T | 1 |
| Higami, T | 1 |
| Ishizuka, T | 1 |
| Yoshiyasu, M | 1 |
| Bando, K | 1 |
| Yoshimura, K | 1 |
| Kagaya, T | 1 |
| Saze, Z | 1 |
| Yasutome, M | 2 |
| Hiruma, K | 1 |
| Ohshima, T | 1 |
| Yamada, R | 1 |
| Hatori, S | 1 |
| Makino, T | 1 |
| Yamazaki, Y | 1 |
| Takanashi, Y | 1 |
| Hanada, N | 1 |
| Inoue, K | 1 |
| Osako, T | 1 |
| Kuriwaki, K | 1 |
| Mochinaga, M | 1 |
| Ueki, K | 1 |
| Wakakuwa, R | 1 |
| Ishizuka, D | 1 |
| Tada, T | 1 |
| Mouri, T | 1 |
| Ogawa, M | 1 |
| Mitsuyama, Y | 1 |
| Yamagata, T | 1 |
| Kosuge, M | 1 |
| Ushigome, T | 1 |
| Eto, K | 1 |
| Anazawa, S | 1 |
| Arai, Y | 1 |
| Inaba, Y | 1 |
| Yamaura, H | 1 |
| Matsueda, K | 1 |
| Kagawa, S | 1 |
| Fujiwara, T | 1 |
| Nishizaki, M | 1 |
| Uno, F | 1 |
| Teraishi, F | 1 |
| Gouchi, A | 1 |
| Matsuoka, J | 1 |
| Ichimura, T | 1 |
| Abeshima, S | 1 |
| Hasegawa, N | 1 |
| Kawabata, M | 1 |
| Egami, K | 1 |
| Maruta, F | 1 |
| Koide, N | 1 |
| Sugiyama, A | 2 |
| Miyagawa, S | 1 |
| Ohi, A | 1 |
| Senju, T | 1 |
| Mizuno, N | 1 |
| Sawaki, A | 1 |
| Yamao, K | 1 |
| Yoshino, T | 1 |
| Jeung, HC | 1 |
| Rha, SY | 1 |
| Cho, BC | 1 |
| Yoo, NC | 1 |
| Roh, JK | 1 |
| Roh, WJ | 1 |
| Chung, HC | 1 |
| Oguro, A | 1 |
| Nanri, M | 1 |
| Ujiie, K | 1 |
| Iitaka, D | 1 |
| Koh, T | 1 |
| Yamazaki, J | 1 |
| Katsumata, K | 1 |
| Hisada, M | 1 |
| Ishizaki, T | 1 |
| Wada, T | 1 |
| Katakura, Y | 1 |
| Nakahara, K | 1 |
| Itoh, F | 1 |
| Nagata, H | 1 |
| Hatano, E | 1 |
| Asechi, H | 1 |
| Narita, M | 1 |
| Yanagida, A | 1 |
| Yasuchika, K | 1 |
| Ikai, I | 1 |
| Uemoto, S | 1 |
| Yonei, A | 1 |
| Kawano, F | 1 |
| Taneda, Y | 1 |
| Ichinari, H | 1 |
| Mine, K | 1 |
| Kimura, T | 2 |
| Noda, Y | 1 |
| Hioki, J | 1 |
| Hokita, S | 2 |
| Uchida, M | 1 |
| Harada, K | 1 |
| Homma, N | 1 |
| Ogata, N | 1 |
| Funada, R | 1 |
| Shibasaki, K | 1 |
| Kawamura, S | 1 |
| Tei, M | 1 |
| Shimada, E | 1 |
| Okumura, S | 1 |
| Ohnishi, T | 1 |
| Kanoh, T | 1 |
| Tono, T | 1 |
| Yano, K | 1 |
| Monden, T | 1 |
| Nakatani, K | 1 |
| Nishimura, K | 1 |
| Shimoda, T | 1 |
| Azuma, M | 1 |
| Katada, C | 1 |
| Saigenji, K | 1 |
| Murahashi, K | 1 |
| Mino, A | 1 |
| Takagaki, K | 1 |
| Nishino, K | 1 |
| Sowa, M | 1 |
| Ogata, K | 1 |
| Ohchi, T | 1 |
| Doi, K | 1 |
| Matsuo, A | 1 |
| Kudo, K | 1 |
| Ootao, R | 1 |
| Matsumoto, S | 1 |
| Teramukai, S | 1 |
| Ishiwata, R | 1 |
| Fukushima, M | 1 |
| Hampton, T | 1 |
| Kohno, H | 1 |
| Okajima, A | 1 |
| Tsugane, K | 1 |
| Takenouchi, Y | 1 |
| Ogawa, A | 1 |
| Taguchi, T | 1 |
| Itoh, J | 1 |
| Munakata, A | 1 |
| Yajima, K | 1 |
| Kurosaki, R | 1 |
| Kurosaki, I | 2 |
| Matsuo, H | 1 |
| Nakamura, R | 1 |
| Kiyota, T | 1 |
| Yoshida, M | 1 |
| Kumai, K | 1 |
| Nimura, H | 1 |
| Aoki, H | 1 |
| Mitsumori, N | 1 |
| Aiba, K | 1 |
| Kashiwagi, H | 1 |
| Ishida, M | 1 |
| Niguma, T | 1 |
| Mimura, T | 1 |
| Tsutsui, N | 1 |
| Yoshino, M | 1 |
| Tomita, N | 1 |
| Nishigori, T | 1 |
| Iwagami, S | 1 |
| Morise, Z | 1 |
| Sugioka, A | 1 |
| Hoshimoto, S | 1 |
| Aridome, K | 1 |
| Imano, M | 1 |
| Ishida, H | 1 |
| Fujitani, K | 1 |
| Narahara, H | 1 |
| Shimokawa, T | 1 |
| Takagaki, T | 1 |
| Hara, K | 1 |
| Ohkohchi, N | 1 |
| Kizaki, J | 1 |
| Koga, A | 1 |
| Adachi, A | 1 |
| Uchiyama, T | 1 |
| Uchisako, H | 1 |
| Hashimoto, H | 1 |
| Ikebe, T | 1 |
| Yoshioka, H | 1 |
| Inagaki, D | 1 |
| Katayama, K | 1 |
| Shiraishi, R | 1 |
| Tanabe, H | 1 |
| Tani, K | 1 |
| Oosawa, H | 1 |
| Tsuji, Y | 1 |
| Tamura, F | 1 |
| Mizushima, T | 1 |
| Nagashima, H | 1 |
| Oura, K | 1 |
| Kukitsu, T | 1 |
| Sumiyoshi, T | 1 |
| Yoshizaki, N | 1 |
| Kondo, H | 1 |
| Masuda, T | 1 |
| Kuwahara, A | 1 |
| Nakadaira, K | 1 |
| Ueki, H | 1 |
| Konno, H | 1 |
| Kamiya, K | 1 |
| Nakamura, S | 1 |
| Saitoh, K | 1 |
| Shirasaka, T | 1 |
| Shinohara, H | 1 |
| Nomura, E | 1 |
| Nishiguchi, K | 1 |
| Okuzawa, M | 1 |
| Chon, Y | 1 |
| Hara, H | 1 |
| Tanigawa, N | 1 |
| Doi, S | 1 |
| Naoi, M | 1 |
| Nishimura, G | 1 |
| Kayahara, M | 1 |
| Shimizu, K | 1 |
| Miwa, K | 1 |
| Yamamura, J | 1 |
| Kawasaki, Y | 1 |
| Ohtsuru, M | 1 |
| Kobayakawa, K | 1 |
| Oka, H | 1 |
| Yamamura, M | 1 |
| Hayashi, Y | 1 |
| Yoshioka, I | 1 |
| Inokuchi, M | 1 |
| Iwata, K | 1 |
| Ajisaka, H | 1 |
| Kaji, M | 1 |
| Yabushita, K | 1 |
| Miwa, A | 1 |
| Morikawa, A | 1 |
| Okabe, R | 1 |
| Ozaki, K | 1 |
| Koyama, Y | 1 |
| Emoto, T | 1 |
| Yoshikawa, K | 1 |
| Fujikawa, M | 1 |
| Hamada, E | 1 |
| Naka, Y | 1 |
| Komaki, T | 1 |
| Umekita, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Trial of Cisplatin Combined With Oral TS-1 in Patients With Advanced Solid Tumors With Different Degrees of Liver Dysfunction[NCT03519074] | Phase 2 | 48 participants (Anticipated) | Interventional | 2016-07-22 | Recruiting | ||
| Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer; Multicenter Randomized Phase 3 Study[NCT02114359] | Phase 3 | 111 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| Phase III Study of Adjuvant Capecitabine vs Observation Alone in Curatively Resected Stage IB (by AJCC 6th Edition) Gastric Cancer(KCSG ST14-05)[NCT01917552] | Phase 3 | 870 participants (Anticipated) | Interventional | 2013-08-19 | Recruiting | ||
| Randomized Open-label Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced/Metastatic Gastrointestinal Cancers.[NCT02595320] | Phase 2 | 200 participants (Actual) | Interventional | 2015-10-05 | Active, not recruiting | ||
| Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449] | Phase 3 | 338 participants (Actual) | Interventional | 2012-12-31 | Completed | ||
| Phase Ⅱ Clinical Study of RALOX or CAPOX Combined With Bevacizumab in the First-line Treatment of Advanced Colorectal Cancer[NCT03813641] | Phase 2 | 100 participants (Anticipated) | Interventional | 2019-01-28 | Recruiting | ||
| A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer[NCT01291407] | Phase 1 | 27 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
| A Phase II Study Assessing Efficacy and Safety of TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated Metastatic Colorectal Cancer[NCT03517618] | Phase 2 | 41 participants (Actual) | Interventional | 2014-07-05 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
24 reviews available for oxonic acid and Liver Neoplasms
| Article | Year |
|---|---|
Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.
Topics: Allografts; Biopsy; Carcinoma, Hepatocellular; Catheter Ablation; Chemotherapy, Adjuvant; Drug Combi | 2020 |
[A Case of Rhabdomyolysis Related to SOX Therapy for Liver Metastasis of Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Hepatectomy; Humans; Liver | 2017 |
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Topics: Adenocarcinoma; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Drug Combination | 2017 |
[A Distal Bile Duct Carcinoma Patient Who Underwent Surgical Resection for Liver Metastasis].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neo | 2018 |
[A case of liver metastasis from gastric cancer responding completely to S-1/docetaxel chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Hep | 2013 |
[A case of quadruple cancer of the liver, stomach, bladder, and ureter].
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Humans; Liver Neop | 2013 |
[A case of advanced sigmoid colon cancer with metastases in the liver and the paraaortic lymph nodes successfully treated with 5-FU/l-LV and FOLFOX4 followed by S-1 leading to long-term complete response].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Human | 2014 |
[Case report of chemotherapeutic control of a gastric cancer producing granulocyte-colony stimulating factor].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Combinations; Fa | 2014 |
[A case of complete response to multiple liver metastasis of gastric cancer after discontinuation of S-1 administration].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; H | 2014 |
[A case of advanced gastric cancer with tumor embolus in the portal vein and liver metastasis responding to S-1 plus cisplatin chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrect | 2014 |
Preoperative chemotherapy with a trastuzumab-containing regimen for a patient with gastric cancer and hepatic metastases.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Proto | 2014 |
[A case of surgical resection for liver metastasis of gastric cancer with portal vein tumor thrombus].
Topics: Combined Modality Therapy; Drug Combinations; Humans; Liver Neoplasms; Male; Middle Aged; Oxonic Aci | 2014 |
[A case of pancreatic cancer with distant metastasis successfully resected after neoadjuvant chemotherapy with a combination of S-1 and gemcitabine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Gemcitabine; | 2014 |
[A case of gastric cancer with liver metastases achieving a clinical complete response after S-1 plus CDDP therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Com | 2014 |
Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asian | 2015 |
A case of metachronous liver metastasis from neuroendocrine carcinoma of the stomach at 1 year and 10 months after endoscopic submucosal dissection.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Carcinoma, Neuroendocrine; Chemotherapy, Adju | 2017 |
Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy; Chemotherapy, Adjuvant; Drug Combinations; | 2010 |
[A case with multiple liver metastases of gastric cancer responding completely to S-1 therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Humans; Liver Neoplasms; Male; Oxonic Acid | 2010 |
[A successful case of systemic chemotherapy followed by liver resection for advanced hepatocellular carcinoma with highly vascular invasion and multiple pulmonary metastases].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinat | 2011 |
[A case of long-term survival after undergoing S-1 based multidisciplinary therapy for liver metastasis of gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Humans; Liver Neoplasms; Neoadjuva | 2011 |
[A case report of a stage IV gastric cancer patient with rapid progression of liver metastases induced by postoperative anastomotic leakage].
Topics: Adult; Anastomotic Leak; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modalit | 2012 |
[Surgical resection and S-1 administration for the treatment of hepatocellular carcinoma].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinat | 2012 |
[A case of liver metastasis of gastric cancer responding well to TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; CA-19-9 Antigen; Dru | 2004 |
[Hepatic arterial infusion chemotherapy for liver metastases from digestive cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colorectal Neoplasms; Drug | 2006 |
34 trials available for oxonic acid and Liver Neoplasms
| Article | Year |
|---|---|
Phase II trial of neoadjuvant chemotherapy with S-1 and oxaliplatin plus bevacizumab for colorectal liver metastasis (N-SOG 05 trial).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colorectal Neoplasms; Drug | 2017 |
S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Diarrhea; Double-Blind Method; Dru | 2017 |
Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301/TOP002 phase III clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Combinations; Female | 2018 |
A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug | 2019 |
Endostar continuous intravenous infusion combined with S-1 and oxaliplatin chemotherapy could be effective in treating liver metastasis from gastric cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Disease-Free S | 2018 |
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 2019 |
A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2014 |
Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; D | 2014 |
Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chem | 2014 |
Phase II multicenter study of adjuvant S-1 for colorectal liver metastasis: survival analysis of N-SOG 01 trial.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease- | 2015 |
Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Colorectal Neoplasms; Drug Combinations; | 2015 |
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; F | 2016 |
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease | 2016 |
Phase 1 study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2016 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Docetaxel; Drug Combination | 2009 |
Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Follow-Up St | 2010 |
Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2010 |
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Femal | 2010 |
Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Area Under Curve; Carcinoma, Hepatocellular; Disease-Free Sur | 2010 |
Efficacy and safety of S-1 in patients with metastatic breast cancer: retrospective review in a single institution.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; F | 2010 |
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Combinations; | 2012 |
A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Surviva | 2011 |
Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonate | 2012 |
Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisp | 2012 |
Phase II trial of adjuvant chemotherapy with S-1 for colorectal liver metastasis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, | 2013 |
Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combin | 2013 |
Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2003 |
Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Ch | 2003 |
[S-1 monotherapy for pancreatic cancer].
Topics: Administration, Oral; Aged; Anorexia; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2006 |
A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dru | 2006 |
[Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Gallbladder Neoplasms; Humans; Liver Neoplasms; | 2007 |
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free | 2008 |
329 other studies available for oxonic acid and Liver Neoplasms
| Article | Year |
|---|---|
[A Case of Large-Cell Neuroendocrine Carcinoma of the Stomach with Multiple Liver Metastases That Show Complete Response to Multidisciplinary Therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Gastrectomy; H | 2019 |
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Hepatectomy; Humans; Liv | 2019 |
[A Case Report of Advanced Gastric Cancer with Synchronous Liver Metastasis Treated with Conversion Surgery after S-1 plus Oxaliplatin Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Liver | 2019 |
[A Case of Advanced Gastric Cancer with Liver Metastases Treated with Curative Conversion Therapy after S-1 plus Oxaliplatin].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Gastrectomy; Humans; Liver Neopla | 2019 |
[A Case of Gastric Endocrine Carcinoma with a Huge Liver Metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Gastrectomy; Humans; Liver Neoplasm | 2019 |
Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Car | 2020 |
[Long-Term Survival for a Patient with StageⅣ Gastric Cancer with Multiple Liver Metastases for Ten Years Who Was Treated with Only S-1Chemotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; | 2020 |
[Salvage Surgery for Unresectable Advanced Esophagogastric Junction Carcinoma with Multiple Liver Metastases after Successful Second-Line Treatment with Nab-Paclitaxel and Ramucirumab Following a Refractory Response to S-1 plus CDDP Therapy-A Case Report]
Topics: Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplat | 2020 |
Combined ablation-chemotherapy versus chemotherapy alone for pancreatic cancer with liver metastasis: a propensity score matching study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Combined Modality Ther | 2021 |
[A Long-Survived Case of Gastric Cancer with Multiple Liver Metastases Who Underwent Gastrectomy and Received Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2020 |
[A Case of Gastric Neuroendocrine Carcinoma with Rapidly Increasing Liver Metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Drug Com | 2020 |
Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neop | 2017 |
Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplati | 2017 |
[A Case of Long-Term Survival of a Patient with Gastric Cancer with Synchronous Liver Metastasis and Portal Vein Thrombus after Multidisciplinary Treatment].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; | 2017 |
Completely Responsive Multiple Liver Recurrence of Colon Cancer Treated Using Chemotherapy with Oral S-1 and Oxaliplatin Plus Bevacizumab : A Case Report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colonic Neoplasms; Drug Combinati | 2017 |
[A Case of Advanced Gastric Cancer with Synchronous Liver Metastases Responding to Preoperative Combination Chemotherapy with S-1 plus Oxaliplatin(SOX)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dru | 2017 |
[A Case of Advanced Gastric Cancer with Liver Metastasis Treated by Curative Surgery after Chemotherapy Using S-1 plus Oxaliplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Hepatectomy; H | 2017 |
[A Case of Unresectable Gastric Cancer with Multiple Metastases Responding to Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans; Liver Ne | 2017 |
The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neopla | 2018 |
[A Case in Which S-1 plus CDDP and S-1 Therapy Responded to Liver Metastasis Recurrence after Gastric Cancer Operation].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Com | 2018 |
[A Case of Long-Term Survival in Gastric Cancer with Multiple Liver Metastases Successfully Treated by Conversion Surgery after S-1 plus Cisplatin Combination Therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Humans; L | 2018 |
[A Case Report of SOX Treatment for Primary Duodenal Carcinoma with Liver Metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Duodenal Neoplasms; Female; | 2018 |
[A Case of Advanced Gastric Cancer with Multiple Liver Metastases Treated with Curative Conversion Therapy after S-1 plus CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Digestive System Surgical Procedures; Dru | 2018 |
Gallbladder cancer with tumor thrombus in the portal vein: A case report.
Topics: Administration, Intravenous; Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; D | 2018 |
[Severe Liver Injury Due to Sinusoidal Obstruction Syndrome Induced by Oxaliplatin in a Patient with Resectable Colorectal Liver Metastases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Drug Combinations; Hepatectomy; Hepatic | 2018 |
[A Case of Synchronous Liver Metastasis of Ascending Colon Cancer with Pathological Complete Response to S-1/Oxaliplatin (SOX) and Bevacizumab].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colon, Ascending; Colonic Neoplas | 2018 |
Pancreatic Acinar Cell Carcinoma with Multiple Liver Metastases Effectively Treated by S-1 Chemotherapy.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Acinar Cell; Drug Combinations; Endoscopic Ultraso | 2018 |
Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Female; Gastrectom | 2019 |
[A Case of Recurrent Gastric Cancer Successfully Treated by S-1 Chemotherapy].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans | 2019 |
Outcome of postoperative radiation therapy for cholangiocarcinoma and analysis of dose-volume histogram of remnant liver.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cholangiocarcinoma; | 2019 |
Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Hepatocellula | 2013 |
[A case of pancreatic neuroendocrine tumor with excessively-advanced liver metastasis treated with S-1/GEM combination chemotherapy plus the long-acting somatostatin analogue octreotide].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Che | 2013 |
Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protoco | 2013 |
Chemotherapy and resection for gastric cancer with synchronous liver metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations | 2013 |
[A case of synchronous liver metastasis originating from advanced gastric cancer treated with combination chemotherapy involving S-1 and surgical intervention].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Combined Modality The | 2013 |
[Two cases of multiple liver metastases breast cancer successfully treated with combination chemotherapy by S-1, vinorelbine and medroxyprogesterone].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Combinations; Female; | 2013 |
[A case of metastatic colon cancer effectively treated by XELOX and IRIS].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; | 2013 |
A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemo | 2013 |
Impact of chemotherapy with S-1 and oxaliplatin (SOX) in combination with molecular-targeting agents on colorectal liver metastases.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2013 |
Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytid | 2013 |
[A case of recurrent breast cancer with liver metastases showing good response to combination therapy with S-1 plus trastuzumab].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 2013 |
[Efficacy of combined local therapy especially with hepatic arterial infusion for liver metastasis from gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Catheter Ablation; Combined Modality Therapy; Drug Combinatio | 2013 |
[Resection of a synchronous liver metastasis from gastric cancer associated with portal vein tumor thrombosis - a case report].
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Fatal Outcome; Fem | 2013 |
[Multiple hepatic metastases from colon cancer successfully treated with irinotecan and S-1 plus panitumumab as second-line therapy-a case report].
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, | 2013 |
[A case of locally advanced residual gastric cancer treated with combined resection of multiple adjacent organs].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hepatecto | 2013 |
Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytid | 2014 |
[A case of large cell neuroendocrine carcinoma of the stomach with liver metastasis effectively treated with S-1 and CDDP combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocri | 2014 |
[A case of Stage IV sigmoid colon cancer that achieved long-term survival with oral anticancer drugs].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2014 |
[Induction chemotherapy with S-1/oxaliplatin prevented colostomy in a patient with advanced rectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colostomy; Drug Combin | 2014 |
Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetu | 2014 |
Successful management of metachronous liver metastasis after pancreaticoduodectomy for pancreatic ductal carcinoma using hepatectomy and chemotherapy: a case report.
Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Combined Modality Therapy; Deoxycytidine; Drug | 2014 |
[A case of S-1/CDDP-resistant recurrent gastric cancer responsive to capecitabine/CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Combined Modality The | 2014 |
[A case of advanced gastric cancer with multiple liver metastases treated with preoperative TS-1/CDDP chemotherapy and resection, with a complete response and survival for 7 years].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Cisplatin; Drug Combinat | 2014 |
Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2014 |
[Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidin | 2014 |
[A case of advanced gastric cancer with multiple liver, lung, and lymph node metastases treated with S-1, CDDP, and trastuzumab].
Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; C | 2014 |
Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, | 2014 |
[A case of liver and para-aortic lymph node metastasis of colorectal cancer responding to S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Aorta; Colonic Neoplasms; Drug Combinations; Female; Humans; | 2015 |
[Complete resection of liver metastases of colorectal cancer after high efficacy bevacizumab, S-1, and CPT -11 combination chemotherapy].
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protoc | 2015 |
[A case of hepatic metastases from colorectal cancer in a long-term survivor undergoing local combined modality therapy for repeated local recurrences].
Topics: Aged, 80 and over; Catheter Ablation; Combined Modality Therapy; Drug Combinations; Embolization, Th | 2014 |
[Treatment of repeat TACE plus S-1 for multiple intrahepatic recurrence of hepatoma and gastric cancer].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Drug Com | 2014 |
[A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Female; Gemc | 2014 |
[A case of AFP-producing esophagogastric junction cancer with liver metastases with a good response to chemotherapy].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Es | 2014 |
[A case of gastric cancer with multiple liver metastases that was successfully treated by chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Cisplatin; Combined Modali | 2014 |
[A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combin | 2014 |
[A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy].
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Drug Combinations; Fatal Outcome; Female; Gemcitabin | 2015 |
Combination of oxaliplatin and S-1 versus sorafenib alone in patients with advanced hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplast | 2014 |
Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Cohor | 2015 |
Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwellin | 2016 |
S-1 versus taxanes for HER2-negative metastatic breast cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Female; Humans | 2016 |
[A Patient with Three-Year Relapse-Free Survival after Surgical Resection for Lung and Liver Metastases of Cholangiocarcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cholangiocarcinoma; Deoxycytidi | 2015 |
[Liver Metastasis in a Gastric Cancer Patient--A Case of Successful Radiofrequency Ablation Combined with Degradable Starch Microspheres Transcatheter Arterial Chemoembolization].
Topics: Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Chemoembolization, Therapeutic; C | 2015 |
[A Case of Pancreatic Cancer with Multiple Liver Metastases That Developed Postoperatively and Showed a Complete Response with S-1 Monotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Human | 2015 |
[Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hepatecto | 2015 |
[Surgical Resection after Chemotherapy for Ampullary Carcinoma with Synchronous Liver Metastasis--Report of a Case].
Topics: Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; | 2015 |
[A Case of Intraductal Growth Pattern Gastrointestinal Stromal Tumor of the Stomach That Was Difficult to Diagnose by Biopsy].
Topics: Aged; Antineoplastic Agents; Biopsy; Drug Combinations; Gastrectomy; Gastrointestinal Stromal Tumors | 2015 |
[A Case Report--A Synchronous Liver Metastasis from Gastric Cancer Treated with Chemotherapy, Surgical Resection of the Gastric Cancer, and RFA of the Liver Metastasis].
Topics: Aged; Antimetabolites, Antineoplastic; Catheter Ablation; Combined Modality Therapy; Drug Combinatio | 2015 |
[A Case of Successful Treatment of Metachronous Liver Metastasis from Gastric Cancer with Hepatectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Combinations; Ga | 2015 |
[Multidisciplinary Therapy for Advanced Gastric Cancer with Liver and Brain Metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality | 2015 |
[A Case of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans | 2015 |
[A Case of Sigmoid Colon Cancer with Synchronous Liver Metastasis, Treated with Laparoscopic Liver Resection after SOX plus BV Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Drug Combinations; Fema | 2015 |
[A Case of Repeat Liver Resection after Laparoscopic Resection of a Synchronous Liver Metastasis of Colon Cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality T | 2015 |
[Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxyc | 2015 |
[A Case of Recurrent Gallbladder Cancer with a Complete Response to S-1 Alternate-Day Administration].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gallbladder Neoplasms | 2016 |
Complete Response Obtained with S-1 Plus CDDP Therapy in a Patient with Multiple Liver Metastases from Gastric Cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Cisp | 2015 |
Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoembryonic Antigen; Colorectal Neoplasms; Drug Combination | 2016 |
[Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cholangiocarcinoma; Deoxy | 2016 |
Repeated Hepatectomy for Recurrent Intrahepatic Cholangiolocellular Carcinoma: Report of a Case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cholangiocarcinoma; Deoxycyt | 2016 |
[A Patient with Stage IV Advanced Gastric Cancer with Multiple Liver Metastases Living for More Than 6 Years after Treatment with TS-1 Alone].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Humans; Liver Neoplasms; Male; Middle Aged; Neop | 2016 |
[A Case of Long-Term Survival after Combination Therapy for Gastric Cancer with Synchronous Multiple Liver Metastasis].
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Gastrectomy; Hepatectomy | 2016 |
Achieved good response of S-1 and docetaxel combination chemotherapy in two patients with metastatic extramammary Paget's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Fatal Outcome; H | 2017 |
[A Case of Locally Advanced Gallbladder Cancer That Developed Early Multiple Liver Metastasis after Curative Resection, and Achieved Long-TermPartial Remission Using S-1 and Gemcitabine].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinatio | 2016 |
[A case of interstitial pneumonia induced by S-1/irinotecan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinat | 2008 |
[A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Deoxycytidine; Drug Combina | 2008 |
[A case of Stage IV gastric cancer with liver and peritoneal metastases responding completely to tailored S-1/CPT- 11 combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Drug Combinat | 2008 |
[A case of advanced gastric cancer with multiple liver metastases completely responding to combination of paclitaxel and S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastroscopy; Humans; Live | 2008 |
[A case of peritoneal disseminated sigmoid colon cancer with liver metastasis responding to S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Drug Combinations; Humans; | 2008 |
Pathological complete response induced by the combination therapy of S-1 and 24-h infusion of cisplatin in two cases initially diagnosed as inoperable advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 2008 |
[A case of liver metastatic recurrence of bile duct cancer completely responding to single-drug S-1 chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Biomarkers, Tumor; Drug C | 2008 |
Long-term survival after multimodal therapy in a patient demonstrating intrahepatic cholangiocarcinoma with hilar invasion and intrahepatic metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic | 2008 |
Combination therapy of oral fluoropyrimidine anticancer drug S-1 and interferon alpha for HCC patients with extrahepatic metastases.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepato | 2008 |
[Three cases with liver metastasis from gastric or colon cancer successfully treated with S-1 combined with CPT- 11].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; | 2008 |
[Marked efficacy of S-1 against hepatic metastasis of multiple drug-resistant breast cancer--a report of 2 cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Drug Comb | 2008 |
Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antimetabolites, Antineoplastic; Bone Neoplasms; Bre | 2009 |
Quantitative analysis of vascular endothelial growth factor in liver metastases from pancreatic carcinoma as a predictor of chemotherapeutic effect and prognosis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Com | 2008 |
[A case of early recurrence with multiple liver metastases after curative operation of gastric cancer successfully treated by S-1/CDDP combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Drug Combination | 2008 |
Combination therapy with S-1 and pegylated interferon alpha for advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Progression; Drug Combination | 2008 |
[A case of liver and lung metastases in gastric cancer successfully treated with S-1 and paclitaxel mono-therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Liver Neoplasms; Lu | 2008 |
[A case of unresectable advanced gastric cancer successfully treated with continuous S-1 + CPT-11 chemotherapy accompanied by dose reduction against grade 4 hematological adverse event].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Blood Cell Count; Camptothecin; Cell P | 2008 |
[Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Deoxycytidine; Drug Combinations; | 2008 |
[A case of advanced sigmoid colon cancer performed resection of liver metastases after long-term control by S-1 and CPT-11 combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic Antigen; Drug Combina | 2008 |
[A case of simultaneous double cancers with multiple liver metastases responding to S-1+CPT-11].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Camptothecin; Carcinoembryonic Antigen | 2009 |
[A case of complete response (CR) persisting for 3 years and 3 months from combination therapy of S-1 and CDDP in a patient with advanced gastric cancer with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Drug Combinations; Humans; | 2009 |
[Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Drug Co | 2009 |
The usefulness of perfusion-weighted magnetic resonance imaging in advanced pancreatic cancer.
Topics: Aged; Antineoplastic Agents; Deoxycytidine; Drug Combinations; Female; Gemcitabine; Humans; Kaplan-M | 2009 |
[A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic C | 2009 |
[A case of gastric cancer with posterior mediastinal lymph node metastasis responding to combination therapy of Paclitaxel and S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2009 |
[A case of recurrent gastric cancer during adjuvant chemotherapy with S-1, treated by S-1 combination chemotherapy].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, A | 2009 |
[A case of advanced hepatocarcinoma responding to combination therapy of S-1 and PEG-IFN].
Topics: Angiography; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; | 2009 |
[Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case].
Topics: Adenocarcinoma; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineop | 2009 |
[Effect on neoadjuvant chemotherapy using s-1 for unresectable liver metastasis from rectal cancer-a case report].
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Drug Combinations; Female; Hepatectomy; Huma | 2009 |
Preoperative chemotherapy with S-1 and cisplatin for highly advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chem | 2009 |
[A case of chemo-radiation therapy with high degree of efficacy for esophageal cancer with liver metastasis].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2009 |
[A long-term survival case of liver metastasis of gastric cancer under interdisciplinary therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2009 |
[A case of metachronous liver metastasis from gastric cancer treated with multidisciplinary therapy including hepatectomy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Catheter Ablation; Cis | 2009 |
[A case of advanced gastric cancer with liver metastases resected successfully after S-1 monotherapy and S-1/CDDP combination chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2009 |
[A case of successful multimodal treatment for combined hepatocellular and cholangiocarcinoma with portal venous tumor thrombus].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2009 |
[A case of complete response to S-1 therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Combinations; Hepatectomy; Hu | 2009 |
[A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality T | 2009 |
[A case of acinar cell carcinoma of pancreas with liver metastases treated effectively by S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Acinar Cell; Drug Combinations; Gastrectomy; Hepat | 2010 |
[A case of advanced gastric cancer with multiple liver metastases completely responding long term to paclitaxel plus S-1 therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Drug Combinations; Gastrec | 2010 |
[Successful treatment with S-1 + CPT-11 for hepatic metastasis from gastric cancer--a case report].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Combina | 2010 |
[Liver metastasis from sigmoid colon cancer showed a complete response to S-1 after recurrence with FOLFOX6 treatment].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemothe | 2010 |
[A case of multiple pulmonary and remnant liver metastases of hepatocellular carcinoma (HCC) after partial hepatic resection remarkably responding to S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; | 2010 |
[A case of colon cancer with multiple liver metastases responding ot S-1 as third-line treatment following FOLFIRI and FOLFOX].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Camptothecin; Carcinoembryonic Antigen | 2010 |
[A successful case of S-1 chemotherapy for bilateral pulmonary recurrence of hepatocellular carcinoma long after hepatectomy].
Topics: Administration, Oral; Carcinoma, Hepatocellular; Drug Combinations; Hepatectomy; Humans; Liver Neopl | 2010 |
[Long survival of a colon cancer case with synchronous multiple liver metastases responding to S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Female; | 2010 |
[A case of breast cancer with multiple hepatic metastasis successfully treated with S-1/PTX and S-1 chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Combinations; Female; Humans; | 2010 |
[A case of recurrence with liver metastasis after total gastrectomy for StageIA gastric carcinoma successfully treated with S-1/CDDP combination followed by S-1 chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2010 |
[A case of long-term survival after undergoing S-1 treatment and splenectomy for liver, lung and splenic metastases following curative distal gastrectomy for gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; | 2010 |
[A case of luminal B recurrent breast cancer with liver and lymph node metastases successfully treated with combination therapy of S-1 plus trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2010 |
[A case report of bi-weekly docetaxel and S-1 combination chemotherapy for gastric cancer with multiple liver metastases and esophageal invasion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Esophageal Neoplasms; | 2010 |
[Curatively resected case of non-functioning pancreatic neuroendocrine carcinoma with multiple liver metastases after downstaging with S-1 monotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Humans; Liver Neoplasms; Male; Neoplasm St | 2010 |
[A case of advanced gastric cancer responding to S-1/paclitaxel/lentinan as neoadjuvant chemoimmunotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Lentin | 2010 |
The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma.
Topics: AC133 Antigen; Adult; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Combined Chemotherapy Pr | 2011 |
[A very elderly case of recurrent gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of docetaxel (DOC) and S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Com | 2010 |
[S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Female; Gemc | 2010 |
[A case report of advanced gallbladder cancer with multiple liver metastases effectively treated by concentrated therapy with S-1].
Topics: Aged; Drug Combinations; Gallbladder Neoplasms; Humans; Liver Neoplasms; Male; Neoplasm Staging; Oxo | 2010 |
[A case of liver metastasis of pancreatic acinar cell carcinoma treated with S-1 and intra-arterial CDDP combination therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Acinar Cell; Cisplatin; Drug Combinations | 2010 |
[A case of AFP-producing gastric cancer with hepatic metastases that accompanied early gastric cancer treated effectively by chemotherapy].
Topics: Aged; alpha-Fetoproteins; Drug Combinations; Humans; Liver Neoplasms; Oxonic Acid; Stomach Neoplasms | 2010 |
[A case of multi-drug resistant breast cancer with liver metastasis treated effectively by S-1 monotherapy].
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Combinations; Dru | 2010 |
Combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocel | 2010 |
[Long-term survival of patient with gastric cancer treated by S-1 + paclitaxel combination chemotherapy against multiple liver metastases after gastrectomy and adrenalectomy].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents | 2010 |
[A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2010 |
[Long-term disease-free survival following multimodal treatment in a patient with curatively unresectable advanced gastric cancer with metachronous liver metastasis].
Topics: Antimetabolites, Antineoplastic; Catheter Ablation; Combined Modality Therapy; Disease-Free Survival | 2010 |
[A case of elderly advanced gastric cancer patient with multiple liver metastases effectively treated by hepatic arterial infusion chemotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Ph | 2010 |
[A case of gastric endocrine cell carcinoma with liver metastases treated with S-1/CDDP].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Ant | 2010 |
[A case of unresectable multiple hepatic metastases from colorectal cancer successfully treated with IRIS (S-1, CPT-11) therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2010 |
[A long-term survival case of hepatocellular carcinoma with bone metastasis and inferior vena cava tumor thrombus successfully treated with multidisciplinary therapy].
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Thera | 2010 |
Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclo | 2011 |
[A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Fatal Outcom | 2011 |
[A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Acinar Cell; Deoxycytidine; Drug | 2011 |
[Retroperitoneal metastasis of hepatocellular carcinoma - a case report].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinat | 2011 |
[A patient with of metastatic breast cancer with a well-controlled quality of life using S-1 therapy as first-line chemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; Female; | 2011 |
[A resected case of advanced gastric cancer with multiple liver metastasis successfully treated by preoperative and postoperative S-1/CPT-11 combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Camptothecin; Combined Modality Therap | 2011 |
[A case of advanced gastric cancer with multiple liver metastasis responding to S-1 and irinotecan combination therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Drug Combin | 2011 |
[Three cases effectively treated with S-1 therapy for liver metastasis of breast cancer in long term].
Topics: Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Drug Combinations; Female; Humans; Liver Ne | 2011 |
[A case of liver metastasis from gastric cancer responding to S-1/CDDP chemotherapy, allowing partial gastrectomy and left hepatectomy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hepatecto | 2011 |
[A case of gastric cancer with liver metastasis had a good reaction to S-1/CDDP chemotherapy after S-1 chemotherapy was ineffective].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Drug Synergism; Female | 2011 |
Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2013 |
[The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases].
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothe | 2011 |
Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Chemoradiotherapy; Cisplatin; Drug C | 2011 |
[Gemcitabine plus S-1 combination therapy (GS therapy) for pancreatic cancer patients with high-grade hepatic metastasis].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxyc | 2011 |
[A case of long-term survival after curative resection of advanced rectal cancer treated by pre-operative chemoradiotherapy].
Topics: Antimetabolites, Antineoplastic; Chemoradiotherapy; Drug Combinations; Female; Humans; Liver Neoplas | 2011 |
[Curative resection of gallbladder cancer with simultaneous liver metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Drug | 2011 |
[A case of intrahepatic recurrence of intrahepatic cholangiocarcinoma treated with repeated hepatectomy].
Topics: Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; | 2011 |
[A case of complete response to interferon-α and S-1 combination therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; | 2011 |
[A case of successful surgical resection followed by S-1 administration for hepatocellular carcinoma with lung metastases and a tumor thrombus into right atrium].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Dr | 2011 |
[A case of advanced gastric cancer with liver metastases successively treated with S-1/CDDP combination therapy followed by curative resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Drug Combinations; Humans; | 2012 |
[A case of stage IV gastric cancer with multiple liver metastases responding to chemotherapy with weekly PTX after failure of chemotherapy with S-1 and CDDP combination].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cispl | 2012 |
Poorly differentiated neuroendocrine carcinoma of the pancreas responsive to combination therapy with gemcitabine and S-1.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Deoxycytidine; Dru | 2012 |
[Two cases of stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans; Liver Ne | 2012 |
[A case of remnant liver metastases after resection of liver metastases from rectal cancer following treatment with 5-FU, L-OHP and CPT-11, with markedly effective treatment by cetuximab plus S-1].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2012 |
[A case of advanced gastric cancer with multiple liver metastases that achieved long-term survival on monotherapy of S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Bronchiectasis; Drug Combinations; Fatal Outcome; Female; Hum | 2012 |
Programmed chemotherapy for patients with metastatic unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; | 2012 |
[A case of multiple liver metastases of gastric cancer successfully treated by combination chemotherapy of S-1 and paclitaxel].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Humans | 2012 |
Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2012 |
[A case of advanced hepatocellular carcinoma with lung, brain and lymph node metastases recurred 8 years after hepatectomy successfully treated by operation, radiation and systemic chemotherapy using S-1/CDDP].
Topics: Adult; Antimetabolites, Antineoplastic; Brain Neoplasms; Carcinoma, Hepatocellular; Combined Modalit | 2012 |
[A case of pathological complete response after chemotherapy for liver metastasis with subcapsular hemorrhage from gastric cancer:].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Combinati | 2012 |
[A case report of S-1 monotherapy for advanced hepatocellular carcinoma].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Combinations; Fatal Outcome; | 2012 |
[Effective multidisciplinary therapy mainly using S-1+ gemcitabine (GEM) for a case of pancreatic body cancer with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Drug | 2012 |
[A case of far-advanced gastric cancer successfully treated with S-1/paclitaxel/krestin immunochemotherapy, followed by curative resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Immunotherapy; Li | 2012 |
[A case of postoperative liver metastasis from pancreatic carcinoma treated with percutaneous isolated hepatic perfusion(PIHP)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Doxo | 2012 |
[A case of diffuse hepatocellular carcinoma(Vp4) treated by right hepatic trisegmentectomy and multidisciplinary therapy regimens].
Topics: Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinations; Fatal Outcome; Female; Hepa | 2012 |
[A patient with multiple liver metastases of gastric and rectal cancers after laparoscopic sigmoidectomy who responded completely to S-1 therapy followed by open gastrectomy].
Topics: Aged; Antimetabolites, Antineoplastic; Colectomy; Combined Modality Therapy; Drug Combinations; Gast | 2012 |
[A case report of advanced gastric cancer with increased C-reactive protein(CRP) and decreased albumin levels: chemotherapy with nutritional supportive care using eicosapentaenoic acid (EPA)-enriched enteral nutrition agent].
Topics: Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Cisplatin; Drug Combinations; Ei | 2012 |
[A case of gastric neuroendocrine carcinoma with liver metastasis and portal vein invasion successfully treated by S-1 and cisplatin chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cisplatin; Drug C | 2013 |
[Questions on "gemcitabine plus S-1 combination therapy (G-S therapy) for pancreatic cancer with accentuated hepatic metastasis" (by Matsumoto, T. et al) published on Japanese Journal of Gastro-enterology Vol. 108, N0. 12].
Topics: Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Gemcitabine; Humans; Liver Neoplasms; O | 2013 |
[Pathological complete remission using low-dose cisplatin plus S-1 for gastric cancer patient with liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Com | 2013 |
[A case experienced long-term survival after repeat hepatectomy for liver metastases from gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Hepatectomy; Hu | 2013 |
[Clinical study of individual TS-1 therapy for inoperable gastric cancer].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; Femal | 2002 |
[A novel combined chemotherapy using TS-1 and low-dose cisplatin against liver metastasis of gastric cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2002 |
[Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization].
Topics: Adenocarcinoma; Administration, Oral; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combine | 2002 |
Advanced gastric cancer with liver metastases successfully treated with S-1.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Humans; Liver Neop | 2002 |
[A case of stomach cancer in which TS-1 neoadjuvant therapy was effective against multiple hepatic metastasis, allowing a radical cure A surgery].
Topics: Adenocarcinoma, Scirrhous; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combi | 2002 |
[Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Proto | 2003 |
[A case of advanced pancreatic cancer with multiple liver metastasis that improved remarkably with use of low-dose cisplatin and TS-1].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationshi | 2003 |
S-1 in the treatment of advanced and recurrent gastric cancer: current state and future prospects.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug | 2003 |
Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Drug Evaluation; Fe | 2003 |
Longterm control of advanced and recurrent gastric cancer (ARGC) by S-1.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; D | 2003 |
Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehyd | 2003 |
[Remnant gastric cancer in which prolonged no change status was maintained with low-dose TS-1--a case report].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellul | 2003 |
[A case of advanced gastric cancer with lymphangitis carcinomatosa of the lung, successfully treated with paclitaxel and TS-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Drug Resistance, | 2003 |
[A case of advanced gastric cancer which became operable after chemotherapy with combination of TS-1/CDDP and in which complete disappearance of liver metastasis was histopathologically confirmed].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 2003 |
[Four cases of gastric cancer with multiple hepatic metastases successfully treated with TS-1 in combination with low-dose cisplatinum].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2003 |
[A case of hepatocellular carcinoma treated with TS-1].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver N | 2003 |
[A case of advanced gastric cancer with multiple liver metastases responding to TS-1 and CDDP].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adminis | 2003 |
[A case of distant metastasis from advanced gastric cancer treated with TS-1, which maintained NC (no change) for 9 months].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2003 |
[Pancytopenia and ARDS with high dose hepatic arterial infusion].
Topics: Aged; Antimetabolites, Antineoplastic; Cisplatin; Drug Combinations; Female; Fluorouracil; Gastrecto | 2003 |
[A case of malignant gastric outlet stenosis palliated with self-expandable metallic stent and responding to TS-1, an oral fluorouracil derivative].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Gastric Outlet Obstruction; Humans; Liver Neopla | 2004 |
[A case of gastric cancer with multiple liver metastases and spleen metastasis that responded to low-dose CDDP/TS-1 combination therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relat | 2004 |
[Two cases of advanced and recurrent gastric cancer responding markedly to TS-1/CDDP therapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2004 |
[A case of gastric cancer with multiple liver metastases responding completely to TS-1].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Sch | 2004 |
[A case of complete response in a primary lesion treated by combined chemotherapy of TS-1 and CDDP for small cell carcinoma of the stomach with liver metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Adminis | 2004 |
[Weekly administration of paclitaxel as a second-line chemotherapy for advanced and recurrent gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Drug Administration Schedu | 2004 |
[A case of hepatocellular carcinoma with bone metastasis responding to concurrent TS-1/low-dose cisplatin (CDDP) therapy and radiotherapy].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; B | 2004 |
[A case of heterochronous liver metastasis of gastric cancer favorably responding to TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Adminis | 2004 |
[A case of effective treatment of oral TS-1 and intravenous MMC administration for multiple metastases of gastric cancer].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Che | 2004 |
Safety and efficacy of S-1, a novel oral fluorouracil antitumor drug, for a chronic renal failure patient maintained on hemodialysis.
Topics: Administration, Oral; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Kidney | 2004 |
[Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion].
Topics: Administration, Oral; Adult; Aged; Agmatine; Antineoplastic Combined Chemotherapy Protocols; Cisplat | 2004 |
[A case report of the 8 year survivor--unresectable liver metastases from advanced gastric cancer (Stage IV) were completely responsive, after 4 years from a total sequential gastrectomy, combining docetaxel treatment to regress the recurrence].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Do | 2004 |
[Three successful case reports of advanced gastric cancer with chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antig | 2004 |
[A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Combinati | 2004 |
[TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Admi | 2004 |
[A case of advanced gastric cancer with multiple liver metastases successfully treated with TS-1 and CDDP].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration | 2004 |
[Clinical efficacy of TS-1 combined with cisplatin for advanced cardiac gastric cancer with multiple liver metastases--two case reports].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Drug Admini | 2004 |
[Two cases of gastric cancer with multiple liver metastases responding to TS-1 with hepatic arterial infusion of CDDP following low-dose 5-FU and CDDP chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relat | 2005 |
[A case of hepatocellular carcinoma with bone metastasis treated by TS-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Cisplatin | 2005 |
[Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Adm | 2005 |
[A case of advanced gastric cancer effectively treated by TS-1 for 4 years].
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2005 |
[A case of curatively resected AFP producing gastric cancer that responded remarkably to 1 course of TS-1 and showed complete loss of multiple liver metastatic tumors].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Combined Modality Therapy | 2005 |
[Combination chemotherapy with oral TS-1 and low-dose CPT-11 by hepatic arterial infusion for multiple hepatic metastases from colon cancer--a case report].
Topics: Adenocarcinoma; Administration, Oral; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocol | 2005 |
[Effective treatment of unresectable advanced gastric cancer by TS-1-based chemotherapy with a sequential combination of cisplatin (CDDP) and paclitaxel (PTX)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2005 |
[A case of gastric cancer with liver invasion responding to TS-1/low-dose CDDP chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2005 |
[A case of advanced gastric cancer with obstructive jaundice that responded to TS-1/CPT-11 combination therapy after percutaneous transhepatic cholangio drainage].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract; Camptothecin; Combined Modality Thera | 2005 |
[A case of advanced gastric cancer with liver and lung metastases markedly responded to TS-1-based sequential chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplasti | 2005 |
[A case of gastric cancer with liver metastasis resected after the combination chemotherapy with CDDP and TS-1].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2005 |
[A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combine | 2005 |
[A case of gastric cancer with multiple liver metastases effectively treated by hepatic arterial infusion of MMC, TS-1/CDDP therapy, and thermotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 2005 |
[A case of synchronous gastric and hepatocellular carcinoma successfully treated by TS-1 and hepatic arterial infusion chemotherapy (HAI) of low-dose CDDP].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2005 |
[Effective salvage chemotherapy with S-1 alone in a patient with lung metastasis of breast cancer].
Topics: Administration, Oral; Anthracyclines; Antimetabolites, Antineoplastic; Breast Neoplasms; Bridged-Rin | 2005 |
5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine.
Topics: Aged; Antimetabolites, Antineoplastic; beta-Alanine; Cardiovascular Diseases; Colonic Neoplasms; Dru | 2005 |
[A case of AFP-producing gastric cancer with multiple liver metastasis responding to TS-1 and cisplatin combination chemotherapy].
Topics: Adenocarcinoma; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug | 2005 |
[Three advanced gastric cancer cases with liver metastases successfully treated by TS-1/CDDP combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 2006 |
[A case report of poorly-differentiated adenocarcinoma in sigmoid colon cancer with liver and pulmonary metastasis responding to TS-1 and CPT-11].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administrat | 2006 |
[Liver metastasis from sigmoid colon cancer with peritoneal dissemination showed a complete response to TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryoni | 2006 |
[A case of liver metastasis successfully treated with S-1 monotherapy in the patient with recurrent breast cancer].
Topics: Anthracyclines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Bridged-Ri | 2006 |
[Two patients effectively treated with S-1 therapy for liver metastasis of breast cancer resistant to other anticancer drugs].
Topics: Administration, Oral; Anthracyclines; Antimetabolites, Antineoplastic; Breast Neoplasms; Bridged-Rin | 2006 |
[A case of gastric cancer with multiple liver metastases resistant to TS-1 responding to chemotherapy with paclitaxel plus doxifluridine].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administrat | 2006 |
[Successful bi-weekly paclitaxel treatment of an AFP-producing gastric cancer patient with peritoneal dissemination and multiple liver metastasis].
Topics: Aged; alpha-Fetoproteins; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Drug Adminis | 2006 |
[Pancreatic acinar cell carcinoma successfully treated with combination of oral TS-1 and intra-arterial cisplatin].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Acinar Cell; Cispla | 2006 |
[A patient with hepatic, pulmonary, and nodal metastases of colon cancer responding to CPT-11/TS-1 therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colonic Neoplasms; Co | 2006 |
[A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Co | 2006 |
[A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
Topics: Adult; Anorexia; Antimetabolites, Antineoplastic; Bone Neoplasms; Cerebral Hemorrhage; Dihydropyrimi | 2006 |
[S-1 treatment against advanced HCC].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2006 |
[Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Administration | 2006 |
[A case of partial response in liver metastatic lesion from gastric endocrine cell carcinoma treated with TS-1].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Small Cell; Combined Modality Therapy; Drug Admini | 2006 |
[A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Comb | 2006 |
[Multiple hepatic metastases of colon cancer responding to combined therapy with TS-1 and CPT-11--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasm | 2006 |
[A case of advanced gastric cancer with liver metastasis completely responding to CPT-11+low-dose 5-FU+CDDP chemotherapy].
Topics: Adenocarcinoma; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cardi | 2006 |
[A case of rectal cancer with multiple liver metastases responding to TS-1].
Topics: Adenocarcinoma; Ambulatory Care; Antimetabolites, Antineoplastic; Biomarkers, Tumor; CA-19-9 Antigen | 2006 |
[A case of non-curatively resected colon cancer with liver and lymph node metastases treated by TS-1/CPT-11 combination therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic | 2006 |
Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Dihydrouracil Dehydrogenase (NADP); | 2006 |
[A case of advanced gastric cancer with long-term survival treated by chemotherapy and surgical cytoreduction].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combin | 2006 |
[A resected case of advanced gastric cancer with multiple liver metastasis responding to preoperative TS-1/CDDP chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemothe | 2006 |
[Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Anemia; Antimetabolites, Antineoplastic; Drug Administra | 2006 |
[Resolution of liver metastases in response to S-1 monotherapy in advanced pancreatic cancer--a case report].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Clinical Trials, Phase II as Topic; Drug Administra | 2006 |
[Two patients effectively treated by S-1 monotherapy for metastatic pancreatic cancer].
Topics: Adenocarcinoma; Aged; Anorexia; Antimetabolites, Antineoplastic; Clinical Trials, Phase II as Topic; | 2006 |
[Chemotherapy-naïve advanced pancreatic cancer with multiple liver metastases successfully treated by S-1 monotherapy--a case report].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Clinical Trials, Phase II as Topic; Deoxycytidine; | 2006 |
[Partial response of liver metastasis from colon cancer following intermittent oral administration of TS-1 after intra-hepatic arterial single injection of CDDP, doxorubicin and 5-FU].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2006 |
A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Dihydrouracil Dehy | 2006 |
[CR of rectal cancer and synchronous liver and lung metastases obtained with TS-1 plus CPT-11 combination therapy--case report].
Topics: Adenomatous Polyposis Coli; Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Com | 2007 |
Remission of primary duodenal adenocarcinoma with liver metastases with S-1 chemotherapy.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Duodenal Neoplasms; Female | 2007 |
[Retrospective analysis of clinical results in eight patients with advanced hepatocellular carcinoma with lung metastases treated by TS-1].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Administration Schedul | 2007 |
[A case of advanced gastric cancer with liver metastases successfully treated by combination therapy of TS-1 and docetaxel].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration | 2007 |
[A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2007 |
[Clinical efficacy of biweekly paclitaxel and S-1 regimen for 14 gastric cancer patients with liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Administration Schedule; Drug | 2007 |
[A case of advanced gastric cancer with obstructive jaundice due to multiple liver metastasis successfully treated with the following combination therapy of CPT-11 and cisplatin after combination therapy of paclitaxel and TS-1].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Admini | 2007 |
[A case of TS-1 resistant recurrent gastric cancer with lung metastasis responding to TS-1 and irinotecan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Drug | 2007 |
A case of suspected S-1 induced interstitial pneumonia.
Topics: Adult; Antimetabolites, Antineoplastic; Diagnosis, Differential; Drug Combinations; Dyspnea; Female; | 2007 |
[Successful low-dose TS-1 administration in an elderly colon cancer patient with liver metastasis].
Topics: Adenocarcinoma; Aged, 80 and over; Antimetabolites, Antineoplastic; Appendiceal Neoplasms; Colonic N | 2007 |
Successful treatment of S-1 + CDDP followed by salvage EMR for a case with metastatic Barrett's esophageal cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Cisplatin; Drug C | 2007 |
[A case of liver metastasis of gastric cancer undergoing non-curative operation responding completely to combination therapy of S-1 and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 2007 |
[Long survival of a colon cancer case with multiple liver metastases cured by multidisciplinary therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Catheter Ablation; Cisplatin; Co | 2007 |
Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Creatinine; D | 2007 |
Cancer drug trials show modest benefit: drugs target liver, gastric, head and neck cancers.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzenesulfonates; | 2007 |
[Complete remission of hepatic metastasis of gastric cancer with CPT-11].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Administration Schedule; | 2007 |
[A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Epi | 2007 |
[Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine | 2007 |
[Complete resection of advanced gastric cancer with multiple liver metastases following a bypass operation and one year of chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 2007 |
[A case report of S-1 monotherapy as first-line treatment for metastatic gallbladder cancer].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Comb | 2007 |
[Two cases of advanced extrahepatic bile duct cancer successfully treated by S-1 monotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Drug | 2007 |
A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Dru | 2007 |
Successful preoperative chemotherapy with S-1 plus low-dose cisplatin for advanced gastric cancer with synchronous liver metastases: report of 2 cases.
Topics: Cisplatin; Drug Combinations; Drug Therapy, Combination; Humans; Liver Neoplasms; Male; Middle Aged; | 2007 |
[A case report of successful control of liver metastasis from duodenal cancer with combined S-1 and docetaxel chemotherapy].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combina | 2007 |
Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Agents; Antineoplastic Combined Chemothe | 2007 |
A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1.
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Drug Combinations; Drug Resistance, Neoplasm; Gemcit | 2007 |
[A successful case of liver metastasis from gastric cancer treated with S-1 + induced hypertensive hepatic arterial infusion chemotherapy--a case report].
Topics: Drug Combinations; Gastrectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Age | 2007 |
S-1 plus cisplatin combination therapy for the patients with primary liver carcinomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; D | 2007 |
The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Drug Combinations; Endo | 2007 |
[A case of sigmoid colon cancer with multiple liver metastases responding to S-1].
Topics: Aged; Biomarkers, Tumor; Drug Combinations; Female; Humans; Liver Neoplasms; Oxonic Acid; Sigmoid Ne | 2008 |
Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothe | 2008 |
[Therapeutic experience of S-1 plus other drug combination therapy for synchronia multiple liver metastases of gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Liver Neopl | 2008 |
[A case of complete response treated by gastrectomy with lymphadenectomy and combined chemotherapy of peroral S-1 and CDDP by arterial infusion for gastric cancer with multiple liver metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrect | 2008 |
[A case of unresectable advanced gallbladder cancer successfully treated by oral S-1 and hepatic arterial infusion (HAI) of low-dose CDDP therapy].
Topics: Administration, Oral; Angiography; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor | 2008 |
[Multiple hepatic metastases and ovarian metastases of colon cancer responding to combined therapy with S-1 and CPT-11--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinations; | 2008 |
[A case of metastatic gastric endocrine cell carcinoma which could be curably resected after chemotherapy with S-1/CDDP].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Ce | 2008 |
[A long-term survival case of unresectable malignant pancreatic endocrine tumor successfully treated with systemic chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Islet Ce | 2008 |
[Recurrent gallbladder carcinoma treated with combination chemotherapy with gemcitabine, CPT-11 and S-1--a successful case with metastatic tumors replaced by marked calcification].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineopla | 2008 |
Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) on liver metastasis of xenotransplanted human colon carcinoma.
Topics: Animals; Antimetabolites, Antineoplastic; Colonic Neoplasms; Drug Combinations; Humans; Liver Neopla | 1999 |
[Combined effect of S-1 and CDDP as a modulator for colon 26 liver metastasis].
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Cisplatin; Colonic Neoplasms; Drug Combinatio | 2000 |
[A case of stage IV gastric cancer with multiple liver metastases and carcinomatous ascites responding to TS-1 for six months before progression].
Topics: Aged; Antimetabolites, Antineoplastic; Ascitic Fluid; Disease Progression; Drug Combinations; Humans | 2001 |
[A case of hepatic metastasis of gastric cancer responding to TS-1, administered for two consecutive weeks and one week rest].
Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug | 2001 |
[A case report of rectal cancer with liver and pulmonary metastases responding to TS-1].
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2001 |
[A case of advanced gastric cancer producing alpha fetoprotein with multiple liver metastases responding to TS-1 after TAE].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Drug Administration Sched | 2001 |
[A patient with advanced gastric cancer in the gastric tube whose QOL was improved by TS-1].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2002 |
[Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2002 |
[A case of gastric cancer with multiple liver metastases responding to TS-1].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Dru | 2002 |
[Successful treatment of gastric cancer accompanied by multiple liver metastases with TS-1 followed by curative gastrectomy affiliation].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Drug Combinations; Female; Humans; Liver Neop | 2002 |